Regulation	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
AP-1	B-protein
,	O
NFAT	B-protein
,	O
and	O
STAT1	B-protein
nuclear	O
import	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
by	O
noninvasive	O
delivery	O
of	O
peptide	O
carrying	O
the	O
nuclear	B-protein
localization	I-protein
sequence	I-protein
of	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
.	O

Activation	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
by	O
Ags	B-protein
or	O
cytokines	B-protein
results	O
in	O
translocation	O
of	O
the	O
transcription	B-protein
factors	I-protein
NF-kappa	B-protein
B	I-protein
,	O
AP-1	B-protein
,	O
NFAT	B-protein
,	O
and	O
STAT	B-protein
from	O
the	O
cytoplasm	O
into	O
the	O
nucleus	O
.	O

The	O
first	O
step	O
in	O
the	O
nuclear	O
import	O
process	O
is	O
recognition	O
of	O
a	O
nuclear	B-protein
localization	I-protein
sequence	I-protein
(	O
NLS	B-protein
)	O
within	O
the	O
karyophilic	B-protein
protein	I-protein
by	O
a	O
cytoplasmic	B-protein
receptor	I-protein
such	O
as	O
the	O
importin	B-protein
(	I-protein
karyopherin	I-protein
)	I-protein
-alpha	I-protein
subunit	I-protein
.	O

The	O
NLSs	B-protein
of	O
NF-kappa	B-protein
B	I-protein
,	O
AP-1	B-protein
,	O
and	O
NFAT	B-protein
differ	O
and	O
the	O
NLS	B-protein
of	O
STAT1	B-protein
has	O
not	O
yet	O
been	O
identified	O
.	O

Herein	O
we	O
demonstrate	O
that	O
the	O
inducible	O
nuclear	O
import	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
AP-1	B-protein
,	O
NFAT	B-protein
,	O
and	O
STAT1	B-protein
in	O
Jurkat	B-cell_line
T	I-cell_line
lymphocytes	I-cell_line
is	O
significantly	O
inhibited	O
by	O
a	O
cell-permeable	O
peptide	O
carrying	O
the	O
NLS	B-protein
of	O
the	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
subunit	I-protein
.	O

NLS	B-protein
peptide-mediated	O
disruption	O
of	O
the	O
nuclear	O
import	O
of	O
these	O
transcription	B-protein
factors	I-protein
results	O
in	O
inhibition	O
of	O
I	O
kappa	O
B	O
alpha	O
and	O
IL-2	O
gene	O
expression	O
,	O
processes	O
dependent	O
on	O
NF-kappa	B-protein
B	I-protein
or	O
the	O
combination	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
AP-1	B-protein
,	O
and	O
NFAT	B-protein
.	O

Further	O
,	O
we	O
show	O
that	O
inhibitory	O
NLS	B-protein
peptide	O
interacts	O
in	O
vitro	O
with	O
a	O
cytoplasmic	B-protein
NLS	I-protein
receptor	I-protein
complex	I-protein
comprised	O
of	O
the	O
Rch1/importin	B-protein
(	I-protein
karyopherin	I-protein
)	I-protein
-beta	I-protein
heterodimer	I-protein
expressed	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
the	O
inducible	O
nuclear	O
import	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
AP-1	B-protein
,	O
NFAT	B-protein
,	O
and	O
STAT1	B-protein
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
can	O
be	O
regulated	O
by	O
NLS	B-protein
peptide	O
delivered	O
noninvasively	O
to	O
the	O
cytoplasm	O
of	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
to	O
target	O
members	O
of	O
the	O
importin	B-protein
(	I-protein
karyopherin	I-protein
)	I-protein
-alpha	I-protein
beta	I-protein
NLS	B-protein
receptor	I-protein
complex	I-protein
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Cha	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
T	NULL
‘	NULL
.CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
#	NULL
s	NULL
me	NULL
Journal	NULL
of	NULL
Regulation	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
4D	NULL
Immunolo	NULL
gy	NULL
STATA	NULL
Nuclear	NULL
Import	NULL
in	NULL
T	NULL
Lymphocytes	NULL
by	NULL
Noninvasive	NULL
Delivery	NULL
of	NULL
Peptide	NULL
Carrying	NULL
the	NULL
Nuclear	NULL
Localization	NULL
Sequence	NULL
of	NULL
NF-	NULL
KB	NULL
p50	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Troy	NULL
R.	NULL
Torgerson	NULL
,	NULL
Ann	NULL
D.	NULL
Colosia	NULL
,	NULL
John	NULL
P.	NULL
Donahue	NULL
,	NULL
Yao-Zhong	NULL
Lin	NULL
and	NULL
Jacek	NULL
Hawiger	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:6084-6092	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/11/6084	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
69	NULL
articles	NULL
,	NULL
40	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/11/6084.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Regulation	NULL
of	NULL
NF-B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
Nuclear	NULL
Import	NULL
in	NULL
T	NULL
Lymphocytes	NULL
by	NULL
Noninvasive	NULL
Delivery	NULL
of	NULL
Peptide	NULL
Carrying	NULL
the	NULL
Nuclear	NULL
Localization	NULL
Sequence	NULL
of	NULL
NF-B	NULL
p50	NULL
'	NULL
Troy	NULL
R.	NULL
Torgerson	NULL
,	NULL
Ann	NULL
D.	NULL
Colosia	NULL
,	NULL
John	NULL
P.	NULL
Donahue	NULL
,	NULL
Yao-Zhong	NULL
Lin	NULL
,	NULL
and	NULL
Jacek	NULL
Hawiger®	NULL
Activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
by	NULL
Ags	NULL
or	NULL
cytokines	NULL
results	NULL
in	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT	NULL
from	NULL
the	NULL
cytoplasm	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
first	NULL
step	NULL
in	NULL
the	NULL
nuclear	NULL
import	NULL
process	NULL
is	NULL
recognition	NULL
of	NULL
a	NULL
nuclear	NULL
localization	NULL
sequence	NULL
(	NULL
NLS	NULL
)	NULL
within	NULL
the	NULL
karyophilic	NULL
protein	NULL
by	NULL
a	NULL
cytoplasmic	NULL
receptor	NULL
such	NULL
as	NULL
the	NULL
importin	NULL
(	NULL
karyopherin	NULL
)	NULL
-a	NULL
&	NULL
subunit	NULL
.	NULL

The	NULL
NLSs	NULL
of	NULL
NF-xB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
differ	NULL
and	NULL
the	NULL
NLS	NULL
of	NULL
STAT1	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

Herein	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
inducible	NULL
nuclear	NULL
import	NULL
of	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
is	NULL
significantly	NULL
inhibited	NULL
by	NULL
a	NULL
cell-permeable	NULL
peptide	NULL
carrying	NULL
the	NULL
NLS	NULL
of	NULL
the	NULL
NF-B	NULL
p50	NULL
subunit	NULL
.	NULL

NLS	NULL
peptide-mediated	NULL
disruption	NULL
of	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
results	NULL
in	NULL
inhibition	NULL
of	NULL
and	NULL
IL-2	NULL
gene	NULL
expression	NULL
,	NULL
processes	NULL
dependent	NULL
on	NULL
NF-sB	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
NF-B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
.	NULL

Further	NULL
,	NULL
we	NULL
show	NULL
that	NULL
inhibitory	NULL
NLS	NULL
peptide	NULL
interacts	NULL
in	NULL
vitro	NULL
with	NULL
a	NULL
cytoplasmic	NULL
NLS	NULL
receptor	NULL
complex	NULL
comprised	NULL
of	NULL
the	NULL
Reh1/importin	NULL
(	NULL
karyopherin	NULL
)	NULL
-	NULL
heterodimer	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
inducible	NULL
nuclear	NULL
import	NULL
of	NULL
NF-B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
NLS	NULL
peptide	NULL
delivered	NULL
noninvasively	NULL
to	NULL
the	NULL
cytoplasm	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
to	NULL
target	NULL
members	NULL
of	NULL
the	NULL
importin	NULL
(	NULL
karyopherin	NULL
)	NULL
-a	NULL
«	NULL
fB	NULL
NLS	NULL
receptor	NULL
complex	NULL
.	NULL

Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
6084-6092.	NULL
ctivation	NULL
of	NULL
T	NULL
lymphocytes	NULL
by	NULL
Ags	NULL
or	NULL
cytokines	NULL
leads	NULL
to	NULL
A	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
important	NULL
for	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
cell	NULL
adhesion	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
``	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
this	NULL
process	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Upon	NULL
cellular	NULL
activation	NULL
,	NULL
these	NULL
factors	NULL
translo-cate	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
bind	NULL
DNA	NULL
and	NULL
regulate	NULL
gene	NULL
transcription	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT	NULL
are	NULL
constitutively	NULL
expressed	NULL
and	NULL
sequestered	NULL
as	NULL
latent	NULL
factors	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
NF-KB	NULL
p50/p65	NULL
heterodimer	NULL
is	NULL
complexed	NULL
in	NULL
the	NULL
cytoplasm	NULL
with	NULL
inhibitory	NULL
proteins	NULL
,	NULL
the	NULL
most	NULL
extensively	NULL
characterized	NULL
being	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Cellular	NULL
activation	NULL
results	NULL
in	NULL
phosphorylation	NULL
,	NULL
ubiquitination	NULL
,	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
thereby	NULL
releasing	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
for	NULL
import	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
proteins	NULL
exist	NULL
as	NULL
phosphoproteins	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Activation-induced	NULL
dephosphorylation	NULL
by	NULL
calcineurin	NULL
,	NULL
a	NULL
calcium/calmodulin-dependent	NULL
serine-threonine	NULL
phosphatase	NULL
,	NULL
results	NULL
in	NULL
nuclear	NULL
import	NULL
of	NULL
NFAT	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
DNA	NULL
alone	NULL
or	NULL
in	NULL
complex	NULL
with	NULL
AP-1	NULL
proteins	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
STAT	NULL
monomers	NULL
are	NULL
recruited	NULL
to	NULL
activated	NULL
growth	NULL
factor	NULL
or	NULL
cytokine	NULL
receptors	NULL
where	NULL
they	NULL
are	NULL
tyrosine	NULL
phos-phorylated	NULL
by	NULL
Janus	NULL
kinases	NULL
,	NULL
dimerized	NULL
through	NULL
their	NULL
SH2	NULL
do-mains	NULL
,	NULL
and	NULL
then	NULL
rapidly	NULL
imported	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
2	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
July	NULL
23	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
fo	NULL
Health	NULL
Grant	NULL
R37HL30647	NULL
(	NULL
J.H	NULL
.	NULL
)	NULL

and	NULL
by	NULL
the	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Program	NULL
Grant	NULL
5T32GMO7347	NULL
(	NULL
T.R.T	NULL
.	NULL
)	NULL

.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Jacek	NULL
J.	NULL
Hawiger	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
;	NULL
E-mail	NULL
address	NULL
:	NULL
Jacek.Hawiger	NULL
@	NULL
mcmail.vanderbilt.edu	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor-x	NULL
binding	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
NLS	NULL
,	NULL
nuclear	NULL
localization	NULL
se-quence	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
AP-1	NULL
proteins	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
are	NULL
present	NULL
at	NULL
only	NULL
minimal	NULL
levels	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
in	NULL
contrast	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
NFAT	NULL
and	NULL
STAT	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Cellular	NULL
activation	NULL
leads	NULL
to	NULL
de	NULL
novo	NULL
synthesis	NULL
and	NULL
nuclear	NULL
import	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
which	NULL
bind	NULL
DNA	NULL
alone	NULL
or	NULL
in	NULL
complex	NULL
with	NULL
other	NULL
transcription	NULL
factor	NULL
proteins	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
NFAT	NULL
)	NULL
(	NULL
21	NULL
)	NULL
.	NULL

For	NULL
most	NULL
karyophilic	NULL
proteins	NULL
,	NULL
the	NULL
first	NULL
step	NULL
in	NULL
the	NULL
nuclear	NULL
import	NULL
process	NULL
involves	NULL
recognition	NULL
of	NULL
a	NULL
nuclear	NULL
localization	NULL
sequence	NULL
(	NULL
NLS	NULL
)	NULL
within	NULL
the	NULL
protein	NULL
by	NULL
a	NULL
cytoplasmic	NULL
NLS	NULL
receptor	NULL
complex	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Most	NULL
well-characterized	NULL
NLSs	NULL
consist	NULL
of	NULL
clusters	NULL
of	NULL
basic	NULL
amino	NULL
acids	NULL
arranged	NULL
in	NULL
one	NULL
of	NULL
two	NULL
motifs	NULL
:	NULL
a	NULL
classical	NULL
motif	NULL
having	NULL
a	NULL
single	NULL
cluster	NULL
of	NULL
four	NULL
or	NULL
five	NULL
basic	NULL
residues	NULL
,	NULL
or	NULL
a	NULL
bipartite	NULL
motif	NULL
having	NULL
two	NULL
clusters	NULL
of	NULL
basic	NULL
residues	NULL
separated	NULL
by	NULL
a	NULL
spacer	NULL
of	NULL
approximately	NULL
10	NULL
amino	NULL
acids	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Classical	NULL
NLSs	NULL
are	NULL
found	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
while	NULL
bipartite	NULL
NLSs	NULL
are	NULL
found	NULL
in	NULL
the	NULL
AP-1	NULL
subunits	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
(	NULL
27-29	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
proteins	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
two	NULL
sequences	NULL
that	NULL
can	NULL
function	NULL
as	NULL
NLSs	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
primary	NULL
nuclear	NULL
targeting	NULL
activity	NULL
of	NULL
NFAT	NULL
appears	NULL
to	NULL
be	NULL
attributable	NULL
to	NULL
a	NULL
unique	NULL
sequence	NULL
near	NULL
the	NULL
N	NULL
terminus	NULL
composed	NULL
of	NULL
three	NULL
basic	NULL
amino	NULL
acids	NULL
flanked	NULL
by	NULL
a	NULL
motif	NULL
containing	NULL
multiple	NULL
phosphoserines	NULL
targeted	NULL
by	NULL
calcineurin	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
proteins	NULL
,	NULL
STAT1	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
unique	NULL
and	NULL
as	NULL
yet	NULL
unidentified	NULL
NLS	NULL
that	NULL
is	NULL
of	NULL
neither	NULL
classical	NULL
nor	NULL
bipartite	NULL
type	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
variations	NULL
in	NULL
NLSs	NULL
present	NULL
among	NULL
these	NULL
four	NULL
distinct	NULL
transcription	NULL
factors	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
there	NULL
are	NULL
biochemical	NULL
differences	NULL
in	NULL
the	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
their	NULL
nuclear	NULL
import	NULL
.	NULL

At	NULL
least	NULL
two	NULL
known	NULL
pathways	NULL
,	NULL
each	NULL
utilizing	NULL
distinct	NULL
but	NULL
related	NULL
proteins	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
for	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
karyophilic	NULL
proteins	NULL
.	NULL

The	NULL
first	NULL
pathway	NULL
involves	NULL
a	NULL
heterodimeric	NULL
NLS	NULL
receptor	NULL
complex	NULL
,	NULL
known	NULL
as	NULL
importin-	NULL
«	NULL
B	NULL
or	NULL
karyopherin-af	NULL
,	NULL
that	NULL
recognizes	NULL
either	NULL
classical	NULL
or	NULL
bipartite	NULL
NLS	NULL
sequences	NULL
in	NULL
many	NULL
karyophilic	NULL
proteins	NULL
and	NULL
mediates	NULL
their	NULL
import	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Importin-	NULL
«	NULL
(	NULL
karyopherin-a	NULL
«	NULL
)	NULL
binds	NULL
to	NULL
the	NULL
NLS	NULL
motif	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
and	NULL
importin-	NULL
(	NULL
karyopherin-f3	NULL
,	NULL
)	NULL
docks	NULL
the	NULL
entire	NULL
complex	NULL
at	NULL
the	NULL
cytoplasmic	NULL
face	NULL
of	NULL
the	NULL
nuclear	NULL
pore	NULL
.	NULL

Once	NULL
docking	NULL
has	NULL
occurred	NULL
,	NULL
the	NULL
complex	NULL
is	NULL
subsequently	NULL
translocated	NULL
through	NULL
the	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Sequences	NULL
of	NULL
cell-permeable	NULL
and	NULL
non-cell-permeable	NULL
peptides	NULL
``	NULL
Peptide	NULL
Cell-Permeable	NULL
Sequence	NULL
--	NULL
-NLS	NULL
--	NULL
-	NULL
NSO	NULL
VORKROKLMP	NULL
SN5O	NULL
AAVALLPAVLLALLAPVORKRQKLMP	NULL
SNSOM	NULL
AAVALLPAVLLALLAPVORNGQKLMP	NULL
SM	NULL
AAVALLPAVLLALLAPAAADQNQLMP	NULL
CYN50	NULL
CYVORKRQKLMP	NULL
CYNS50M	NULL
CYVORNGQKLMP	NULL
``	NULL
Sequences	NULL
are	NULL
given	NULL
in	NULL
single	NULL
letter	NULL
amino	NULL
acid	NULL
code	NULL
with	NULL
bold	NULL
type	NULL
indicating	NULL
basic	NULL
residues	NULL
important	NULL
for	NULL
NLS	NULL
function	NULL
.	NULL

Underlined	NULL
residues	NULL
constitute	NULL
the	NULL
cell-permeable	NULL
sequence	NULL
derived	NULL
from	NULL
the	NULL
hydrophobic	NULL
(	NULL
h	NULL
)	NULL
domain	NULL
of	NULL
the	NULL
Kaposi	NULL
fibro-blast	NULL
growth	NULL
factor	NULL
signal	NULL
sequence	NULL
(	NULL
46	NULL
)	NULL
.	NULL

pore	NULL
and	NULL
into	NULL
the	NULL
nucleus	NULL
by	NULL
an	NULL
energy-dependent	NULL
process	NULL
involving	NULL
the	NULL
GTPase	NULL
Ran/TC4	NULL
and	NULL
the	NULL
Ran	NULL
interacting	NULL
factor	NULL
NTF2/p10	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Homologues	NULL
of	NULL
importin-	NULL
«	NULL
(	NULL
60	NULL
kDa	NULL
)	NULL
have	NULL
been	NULL
described	NULL
in	NULL
several	NULL
species	NULL
including	NULL
Xenopus	NULL
,	NULL
yeast	NULL
,	NULL
Drosophila	NULL
,	NULL
mouse	NULL
,	NULL
and	NULL
human	NULL
.	NULL

To	NULL
date	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
Reh1/hSRP1a	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
and	NULL
NPI-1/	NULL
hSRP1	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
four	NULL
other	NULL
human	NULL
importin-a	NULL
homologues	NULL
have	NULL
been	NULL
cloned	NULL
including	NULL
Qipl	NULL
and	NULL
hSRP1y	NULL
(	NULL
37-40	NULL
)	NULL
.	NULL

Importin-B	NULL
(	NULL
karyopherin-B	NULL
,	NULL
)	NULL
(	NULL
97	NULL
kDa	NULL
)	NULL
has	NULL
also	NULL
been	NULL
characterized	NULL
in	NULL
several	NULL
different	NULL
species	NULL
(	NULL
41-43	NULL
)	NULL
.	NULL

The	NULL
second	NULL
pathway	NULL
of	NULL
nuclear	NULL
import	NULL
involves	NULL
an	NULL
importin-B-related	NULL
protein	NULL
,	NULL
termed	NULL
transportin	NULL
or	NULL
karyopherin-B	NULL
,	NULL
,	NULL
which	NULL
binds	NULL
the	NULL
M9	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
hnRNP	NULL
A1	NULL
protein	NULL
,	NULL
but	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
classical	NULL
or	NULL
bipartite	NULL
NLSs	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Initial	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
transportin	NULL
or	NULL
its	NULL
yeast	NULL
homologue	NULL
,	NULL
Kap104p	NULL
,	NULL
can	NULL
perform	NULL
both	NULL
the	NULL
NLS-binding	NULL
and	NULL
nuclear	NULL
pore	NULL
docking	NULL
functions	NULL
of	NULL
the	NULL
heterodimeric	NULL
impor-tin-eB	NULL
complex	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
nuclear	NULL
import	NULL
machinery	NULL
recognizes	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
,	NULL
the	NULL
new	NULL
strategy	NULL
of	NULL
noninvasive	NULL
peptide	NULL
delivery	NULL
was	NULL
used	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Using	NULL
this	NULL
technique	NULL
,	NULL
peptides	NULL
bearing	NULL
the	NULL
NF-kB	NULL
p50	NULL
NLS	NULL
were	NULL
delivered	NULL
into	NULL
the	NULL
cytoplasm	NULL
of	NULL
intact	NULL
cells	NULL
and	NULL
the	NULL
activation-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
each	NULL
transcription	NULL
factor	NULL
analyzed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NLS	NULL
peptides	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
NLS	NULL
peptide	NULL
significantly	NULL
inhibited	NULL
the	NULL
signal-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
and	NULL
the	NULL
subsequent	NULL
induction	NULL
of	NULL
genes	NULL
activated	NULL
by	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
factors	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
inhibitory	NULL
p50	NULL
NLS	NULL
peptide	NULL
binds	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
NLS	NULL
receptor	NULL
complex	NULL
,	NULL
Reh1/impor-tin-	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
diverse	NULL
NLS	NULL
motifs	NULL
in	NULL
these	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
single	NULL
NLS	NULL
peptide	NULL
delivered	NULL
noninvasively	NULL
to	NULL
the	NULL
cytoplasm	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
to	NULL
target	NULL
members	NULL
of	NULL
the	NULL
importin	NULL
(	NULL
karyopherin	NULL
)	NULL
family	NULL
of	NULL
NLS	NULL
receptors	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Reh1l/importin-B	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
of	NULL
transcription	NULL
factor	NULL
nuclear	NULL
import	NULL
was	NULL
subsequently	NULL
coupled	NULL
to	NULL
attenuation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
The	NULL
peptides	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
were	NULL
synthesized	NULL
manually	NULL
by	NULL
a	NULL
stepwise	NULL
solid-phase	NULL
synthesis	NULL
method	NULL
using	NULL
Boc	NULL
chemistry	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Polyclonal	NULL
antiserum	NULL
specific	NULL
for	NULL
IxBa	NULL
(	NULL
amino	NULL
acids	NULL
1-29	NULL
)	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
)	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Polyclonal	NULL
c-Jun	NULL
antiserum	NULL
and	NULL
affinity-purified	NULL
polyclonal	NULL
c-Fos	NULL
Ab	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
Stephen	NULL
Hann	NULL
(	NULL
Vanderbilt	NULL
University	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
)	NULL
.	NULL

The	NULL
mAb	NULL
7A6	NULL
,	NULL
specific	NULL
for	NULL
human	NULL
(	NULL
NFAT2	NULL
)	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Gerald	NULL
Crabtree	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Polyclonal	NULL
Abs	NULL
and	NULL
mAbs	NULL
to	NULL
ISGF3/STAT1	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
Mark	NULL
Boothby	NULL
(	NULL
Vanderbilt	NULL
University	NULL
)	NULL
.	NULL

Polyclonal	NULL
Abs	NULL
to	NULL
Reh1	NULL
and	NULL
importin-B	NULL
were	NULL
gifts	NULL
from	NULL
Dr.	NULL
Dirk	NULL
Gérlich	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Affinity-purified	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
and	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
were	NULL
purchased	NULL
from	NULL
Pierce	NULL
(	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Expression	NULL
plasmids	NULL
encoding	NULL
full-length	NULL
human	NULL
Reh1	NULL
and	NULL
6085	NULL
importin-	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Dirk	NULL
Gérlich	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Recombinant	NULL
Rch1	NULL
and	NULL
importin-	NULL
were	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
and	NULL
purified	NULL
from	NULL
cell	NULL
lysates	NULL
by	NULL
standard	NULL
chromatographic	NULL
procedures	NULL
using	NULL
Q	NULL
Sepha-rose	NULL
Fast	NULL
Flow	NULL
followed	NULL
by	NULL
Superdex	NULL
200	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Peptide	NULL
treatment	NULL
and	NULL
cell	NULL
extract	NULL
preparation	NULL
Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Cellgro	NULL
,	NULL
Fisher	NULL
,	NULL
Atlanta	NULL
,	NULL
GA	NULL
)	NULL
supplemented	NULL
;	NULL
with	NULL
50	NULL
U/ml	NULL
penicillin	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
.	NULL

For	NULL
each	NULL
assay	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
suspended	NULL
in	NULL
4.5	NULL
ml	NULL
fresh	NULL
culture	NULL
media	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
(	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
)	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Peptides	NULL
were	NULL
dissolved	NULL
in	NULL
0.5	NULL
ml	NULL
HBSS	NULL
without	NULL
Ca	NULL
``	NULL
*	NULL
or	NULL
Mg**	NULL
(	NULL
Cellgro	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
5	NULL
nM	NULL
;	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
/	NULL
ionomycin	NULL
(	NULL
2	NULL
uM	NULL
;	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
1	NULL
U/ml	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
48	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
by	NULL
incubation	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.4	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
1	NULL
pg/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
,	NULL
chymostatin	NULL
,	NULL
and	NULL
antipain	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrif-ugation	NULL
,	NULL
the	NULL
supernatant	NULL
saved	NULL
as	NULL
the	NULL
cytoplasmic	NULL
extract	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
pellet	NULL
washed	NULL
in	NULL
1	NULL
ml	NULL
buffer	NULL
A	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
25	NULL
l	NULL
(	NULL
STAT1	NULL
)	NULL
or	NULL
100	NULL
l	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
)	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
1	NULL
ug/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
,	NULL
chymostatin	NULL
,	NULL
and	NULL
antipain	NULL
}	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
IFN-y-stimulated	NULL
cells	NULL
were	NULL
made	NULL
fourfold	NULL
more	NULL
concentrated	NULL
than	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA/	NULL
ionomycin	NULL
because	NULL
of	NULL
the	NULL
relatively	NULL
lower	NULL
concentration	NULL
of	NULL
STAT1	NULL
found	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Samples	NULL
were	NULL
vortexed	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
centrifuged	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
saved	NULL
as	NULL
the	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Pierce	NULL
BCA	NULL
protein	NULL
assay	NULL
and	NULL
equalized	NULL
among	NULL
samples	NULL
using	NULL
buffer	NULL
B	NULL
.	NULL

For	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
,	NULL
buffers	NULL
A	NULL
and	NULL
B	NULL
also	NULL
contained	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
NaF	NULL
.	NULL

Intracellular	NULL
peptide	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
cell	NULL
extract	NULL
ELISA	NULL
.	NULL

Briefly	NULL
,	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
peptide-treated	NULL
cells	NULL
were	NULL
combined	NULL
and	NULL
25	NULL
,	NULL
50	NULL
,	NULL
or	NULL
100	NULL
pl	NULL
used	NULL
to	NULL
coat	NULL
the	NULL
wells	NULL
of	NULL
a	NULL
96-well	NULL
plate	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
adjacent	NULL
wells	NULL
were	NULL
coated	NULL
with	NULL
extracts	NULL
from	NULL
untreated	NULL
cells	NULL
to	NULL
which	NULL
known	NULL
amounts	NULL
of	NULL
peptide	NULL
were	NULL
added	NULL
.	NULL

Following	NULL
a	NULL
16-h	NULL
incubation	NULL
,	NULL
all	NULL
wells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
plus	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
blocked	NULL
with	NULL
BSA	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
Ab	NULL
specific	NULL
for	NULL
the	NULL
LMP	NULL
residues	NULL
present	NULL
in	NULL
each	NULL
peptide	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Peptide-Ab	NULL
complexes	NULL
were	NULL
detected	NULL
with	NULL
anti-rabbit	NULL
IgG	NULL
conjugated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
quantitated	NULL
by	NULL
ELISA	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
The	NULL
following	NULL
oligonucleotides	NULL
,	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
recognition	NULL
sites	NULL
underlined	NULL
,	NULL
were	NULL
used	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
5'-AGCTTAGAGGGGACTTIC	NULL
CGAGAGGA-3	NULL
``	NULL
(	NULL
8	NULL
)	NULL
;	NULL
AP-1	NULL
,	NULL
5-GATCCATGACTCAGAGGAAAACA-3	NULL
``	NULL
(	NULL
49	NULL
)	NULL
;	NULL
NFAT	NULL
,	NULL
5-GATCTTTACATTGGAAAATTTTAT-3	NULL
'	NULL
(	NULL
50	NULL
)	NULL
;	NULL
NFAT/	NULL
AP-1	NULL
,	NULL
5	NULL
-GATCCAGAAAGGAGGAAAAACTGTTTCATACAG-3	NULL
'	NULL
(	NULL
18	NULL
)	NULL
;	NULL
STAT1	NULL
,	NULL
5-GATCGTCGACATTTCCCGTAAATC-3	NULL
'	NULL
(	NULL
51	NULL
)	NULL
;	NULL
and	NULL
NF-Y	NULL
,	NULL
GATCTGAGAATTTTCTGATTGGTTCTGGCGAGTTTGG-3	NULL
'	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
(	NULL
40	NULL
pmol	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
50	NULL
uCi	NULL
[	NULL
a®P	NULL
]	NULL
dATP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
,	NULL
DuPont-New	NULL
England	NULL
Nuclear	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
5	NULL
U	NULL
of	NULL
E.	NULL
coli	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
Klenow	NULL
fragment	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Labeled	NULL
oligonucleotides	NULL
were	NULL
separated	NULL
from	NULL
unin-corporated	NULL
by	NULL
chromatography	NULL
on	NULL
Sephadex	NULL
G50	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

DNA-binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
.	NULL

NF-	NULL
«	NULL
B-and	NULL
AP-1-binding	NULL
reactions	NULL
contained	NULL
5	NULL
pl	NULL
nuclear	NULL
extract	NULL
,	NULL
1	NULL
pg	NULL
poly	NULL
dI-dC	NULL
,	NULL
1	NULL
ug	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
EMSA	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
and	NULL
100,000	NULL
cpm	NULL
P-labeled	NULL
oligonucleotide	NULL
.	NULL

NFAT-	NULL
and	NULL
STAT1-binding	NULL
reactions	NULL
contained	NULL
5	NULL
ul	NULL
nuclear	NULL
extract	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
dI-dC	NULL
,	NULL
and	NULL
100,000	NULL
cpm	NULL
*°P-labeled	NULL
oligonucleotide	NULL
.	NULL

NF-Y-binding	NULL
reactions	NULL
contained	NULL
5	NULL
pl	NULL
nuclear	NULL
extract	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
dI-dC	NULL
,	NULL
EMSA	NULL
buffer	NULL
,	NULL
and	NULL
50,000	NULL
cpm	NULL
**P-labeled	NULL
oligonucleotide	NULL
.	NULL

All	NULL
binding	NULL
reactions	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
and	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
ul	NULL
of	NULL
10X	NULL
EMSA	NULL
gel-loading	NULL
dye	NULL
(	NULL
0.25	NULL
%	NULL
bromphenol	NULL
blue	NULL
,	NULL
0.25	NULL
%	NULL
xylene	NULL
cyanol	NULL
,	NULL
and	NULL
50	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
samples	NULL
were	NULL
run	NULL
in	NULL
4	NULL
%	NULL
polyacrylamide/0.5X	NULL
TBE	NULL
(	NULL
45	NULL
mM	NULL
Tris-borate	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
gels	NULL
prerun	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
for	NULL
60	NULL
min	NULL
at	NULL
100V	NULL
.	NULL

STAT1	NULL
samples	NULL
were	NULL
run	NULL
in	NULL
4	NULL
%	NULL
acrylamide/Tris-glycine	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
380	NULL
mM	NULL
glycine	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
gels	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
onto	NULL
chromatography	NULL
paper	NULL
(	NULL
Whatman	NULL
3Chr	NULL
;	NULL
VWR	NULL
,	NULL
Atlanta	NULL
,	NULL
GA	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
Fuji	NULL
BAS-IIIs	NULL
phosphorimager	NULL
plates	NULL
(	NULL
Fuji	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
quantitation	NULL
and	NULL
then	NULL
to	NULL
Kodak	NULL
Biomax	NULL
MR	NULL
autoradiography	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Ab	NULL
supershift	NULL
analyses	NULL
of	NULL
DNA-binding	NULL
complexes	NULL
were	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6086	NULL
performed	NULL
by	NULL
adding	NULL
subunit-specific	NULL
antiserum	NULL
to	NULL
the	NULL
nuclear	NULL
extract	NULL
immediately	NULL
before	NULL
addition	NULL
of	NULL
other	NULL
binding-reaction	NULL
components	NULL
.	NULL

EMSAs	NULL
to	NULL
detect	NULL
AP-1	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
replaced	NULL
with	NULL
10	NULL
pl	NULL
of	NULL
10	NULL
%	NULL
concentrated	NULL
cytoplasmic	NULL
extract	NULL
prepared	NULL
by	NULL
centrifugation	NULL
in	NULL
Micro-con-30	NULL
concentrators	NULL
(	NULL
Amicon	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Immunoblotting	NULL
Nuclear	NULL
proteins	NULL
(	NULL
50	NULL
pug	NULL
)	NULL
were	NULL
precipitated	NULL
with	NULL
10	NULL
%	NULL
TCA	NULL
and	NULL
the	NULL
protein	NULL
pellet	NULL
resuspended	NULL
in	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
2	NULL
%	NULL
2-ME	NULL
,	NULL
and	NULL
0.025	NULL
%	NULL
bromphenol	NULL
blue	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
heated	NULL
at	NULL
100°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
run	NULL
in	NULL
a	NULL
10	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
mini	NULL
gel	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
proteins	NULL
(	NULL
100	NULL
pug	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
,	NULL
heated	NULL
at	NULL
100°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
run	NULL
in	NULL
an	NULL
8	NULL
%	NULL
SDS	NULL
polyacrylamide	NULL
mini	NULL
gel	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitro-cellulose	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
and	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
in	NULL
TBST	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h.	NULL
Immunoreactive	NULL
proteins	NULL
were	NULL
detected	NULL
using	NULL
Abs	NULL
specific	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
1:8000	NULL
)	NULL
,	NULL
c-Jun	NULL
(	NULL
1:6000	NULL
)	NULL
,	NULL
NFATe	NULL
(	NULL
1:6000	NULL
)	NULL
,	NULL
IxBa	NULL
(	NULL
1:2500	NULL
)	NULL
,	NULL
Rch1	NULL
(	NULL
1:5000	NULL
)	NULL
,	NULL
or	NULL
importin-	NULL
(	NULL
1:5000	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
primary	NULL
Abs	NULL
,	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
goat	NULL
anti-rabbit	NULL
or	NULL
anti-mouse	NULL
horseradish	NULL
peroxidase-conjugated	NULL
Ab	NULL
(	NULL
1:20,000	NULL
;	NULL
Pierce	NULL
)	NULL
,	NULL
developed	NULL
with	NULL
supersignal	NULL
horseradish	NULL
peroxidase	NULL
enhanced	NULL
chemiluminescence	NULL
reagent	NULL
(	NULL
Pierce	NULL
)	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
Biomax	NULL
MR	NULL
film	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
ribonuclease	NULL
protection	NULL
assays	NULL
Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
10	NULL
``	NULL
Jurkat	NULL
T	NULL
cells	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

Anti-sense	NULL
RNA	NULL
probes	NULL
were	NULL
generated	NULL
using	NULL
the	NULL
Riboprobe	NULL
Gemini	NULL
system	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
.	NULL

The	NULL
human	NULL
IL-2	NULL
anti-sense	NULL
RNA	NULL
probe	NULL
(	NULL
280	NULL
nucleotides	NULL
)	NULL
was	NULL
generated	NULL
from	NULL
pGEMIL-2	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Drs	NULL
.	NULL

Geraldine	NULL
Miller	NULL
and	NULL
Marty	NULL
Reich	NULL
,	NULL
Vanderbilt	NULL
University	NULL
)	NULL
.	NULL

The	NULL
human	NULL
B-actin	NULL
anti-sense	NULL
RNA	NULL
probe	NULL
(	NULL
255	NULL
nucleotides	NULL
)	NULL
was	NULL
generated	NULL
from	NULL
a	NULL
plasmid	NULL
provided	NULL
by	NULL
Boehringer-Mannheim	NULL
(	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Ribonuclease	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
RPA	NULL
II	NULL
system	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Briefly	NULL
,	NULL
30	NULL
ug	NULL
Jurkat	NULL
total	NULL
RNA	NULL
and	NULL
160,000	NULL
cpm	NULL
*°P-labeled	NULL
IL-2	NULL
probe	NULL
or	NULL
10	NULL
ug	NULL
Jurkat	NULL
total	NULL
RNA	NULL
and	NULL
80,000	NULL
cpm	NULL
°P-labeled	NULL
B-actin	NULL
probe	NULL
were	NULL
coprecipitated	NULL
with	NULL
ethanol	NULL
.	NULL

Pellets	NULL
were	NULL
resuspended	NULL
in	NULL
hybridization	NULL
buffer	NULL
,	NULL
heated	NULL
to	NULL
90°C	NULL
for	NULL
3	NULL
min	NULL
,	NULL
and	NULL
annealed	NULL
at	NULL
42°C	NULL
for	NULL
16	NULL
h.	NULL
Annealed	NULL
samples	NULL
were	NULL
digested	NULL
with	NULL
RNase	NULL
A	NULL
and	NULL
T	NULL
,	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

The	NULL
resulting	NULL
precipitate	NULL
was	NULL
resuspended	NULL
in	NULL
gel-loading	NULL
solution	NULL
,	NULL
heated	NULL
to	NULL
90°C	NULL
for	NULL
3	NULL
min	NULL
,	NULL
and	NULL
run	NULL
in	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide/TBE	NULL
gel	NULL
containing	NULL
8	NULL
M	NULL
urea	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
Kodak	NULL
Biomax	NULL
MR	NULL
film	NULL
and	NULL
then	NULL
to	NULL
Fuji	NULL
BAS-IIIs	NULL
phosphorimager	NULL
screens	NULL
for	NULL
quantitation	NULL
.	NULL

Preparation	NULL
of	NULL
NLS	NULL
peptide/biotinylated-BSA	NULL
conjugates	NULL
and	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
The	NULL
cysteine-modified	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
wild-type	NULL
(	NULL
CYN50	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
CYN50	NULL
M	NULL
)	NULL
NLS	NULL
peptides	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
were	NULL
conjugated	NULL
to	NULL
BSA	NULL
and	NULL
the	NULL
peptide-BSA	NULL
conjugates	NULL
were	NULL
biotinylated	NULL
as	NULL
described	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
NLS	NULL
peptide/biotinylated-BSA	NULL
conjugate	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
and	NULL
BSA	NULL
(	NULL
200	NULL
ug	NULL
)	NULL
were	NULL
added	NULL
to	NULL
100	NULL
pl	NULL
of	NULL
Jurkat	NULL
T	NULL
cell	NULL
whole-cell	NULL
extract	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
60	NULL
min	NULL
with	NULL
gentle	NULL
rocking	NULL
.	NULL

Aggregates	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
in	NULL
a	NULL
mi-crocentrifuge	NULL
at	NULL
10,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
(	NULL
4°C	NULL
)	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
60	NULL
min	NULL
with	NULL
25	NULL
pl	NULL
of	NULL
packed	NULL
ultralink	NULL
immobilized	NULL
streptavidin	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
bound	NULL
proteins	NULL
were	NULL
washed	NULL
six	NULL
times	NULL
with	NULL
wash	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris-Cl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
80	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
MgCl	NULL
;	NULL
)	NULL
and	NULL
eluted	NULL
with	NULL
200	NULL
pl	NULL
of	NULL
1	NULL
M	NULL
MgCl	NULL
,	NULL
,	NULL
.	NULL

Eluted	NULL
proteins	NULL
were	NULL
precipitated	NULL
with	NULL
10	NULL
%	NULL
TCA	NULL
,	NULL
run	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
mini	NULL
gel	NULL
,	NULL
and	NULL
Western	NULL
blotted	NULL
with	NULL
Abs	NULL
to	NULL
Rch1	NULL
and	NULL
importin-	NULL
.	NULL

Results	NULL
Kinetics	NULL
of	NULL
the	NULL
signal-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT	NULL
!	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
or	NULL
IFN-y	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
mimics	NULL
costimulation	NULL
through	NULL
the	NULL
TCR	NULL
and	NULL
CD28	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
transcription	NULL
factor	NULL
nuclear	NULL
import	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
DNA-binding	NULL
activity	NULL
using	NULL
an	NULL
EMSA	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
were	NULL
maximally	NULL
induced	NULL
by	NULL
30	NULL
,	NULL
60	NULL
,	NULL
10	NULL
,	NULL
and	NULL
10	NULL
min	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
relatively	NULL
slower	NULL
rate	NULL
of	NULL
induc-	NULL
NUCLEAR	NULL
IMPORT	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
AND	NULL
STAT1I	NULL
PMA/ionomycin	NULL
(	NULL
min	NULL
)	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
1	NULL
1	NULL
i	NULL
1	NULL
1	NULL
1	NULL
i	NULL
I	NULL
U	NULL
NF-KB|	NULL
:	NULL
h	NULL
‘	NULL
®	NULL
AP-1I	NULL
:	NULL
“	NULL
Ni	NULL
;	NULL
-	NULL
``	NULL
==	NULL
-d	NULL
beb	NULL
bu	NULL
bd	NULL
be	NULL
bt	NULL
bd	NULL
C	NULL
w	NULL
On	NULL
NF-Y	NULL
I	NULL
:	NULL
'	NULL
o	NULL
10	NULL
20	NULL
30	NULL
40	NULL
so	NULL
eo	NULL
/	NULL
L	NULL
L	NULL
1	NULL
L	NULL
1	NULL
L	NULL
1	NULL
I	NULL
Sy	NULL
w	NULL
Jaw	NULL
|	NULL
G90	NULL
pen	NULL
ve	NULL
STATA	NULL
C	NULL
NS	NULL
C	NULL
g	NULL
FIGURE	NULL
1	NULL
.	NULL

Kinetics	NULL
of	NULL
the	NULL
signal-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
5	NULL
nM	NULL
PMA/2	NULL
uM	NULL
ionomycin	NULL
or	NULL
1	NULL
U/ml	NULL
IFN-y	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
transcription	NULL
factor	NULL
DNA-binding	NULL
activity	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
sections	NULL
of	NULL
autoradiograms	NULL
that	NULL
included	NULL
mobility-shifted	NULL
complexes	NULL
containing	NULL
the	NULL
specific	NULL
*°P-labeled	NULL
DNA	NULL
and	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
STAT1	NULL
,	NULL
or	NULL
the	NULL
constitutively	NULL
expressed	NULL
nuclear	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

NS	NULL
underneath	NULL
STAT1	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
indicates	NULL
a	NULL
nonspecific	NULL
,	NULL
constitutive	NULL
band	NULL
.	NULL

Interferony	NULL
(	NULL
min	NULL
)	NULL
tion	NULL
of	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
requirement	NULL
for	NULL
de	NULL
novo	NULL
AP-1	NULL
synthesis	NULL
following	NULL
agonist	NULL
stimulation	NULL
.	NULL

Because	NULL
NFAT	NULL
DNA	NULL
binding	NULL
to	NULL
a	NULL
human	NULL
DNA	NULL
probe	NULL
requires	NULL
AP-1	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
NFAT	NULL
induction	NULL
are	NULL
coincident	NULL
with	NULL
that	NULL
of	NULL
AP-1	NULL
.	NULL

However	NULL
,	NULL
NFAT	NULL
binding	NULL
to	NULL
a	NULL
murine	NULL
DNA	NULL
probe	NULL
(	NULL
50	NULL
)	NULL
,	NULL
independent	NULL
of	NULL
AP-1	NULL
complexation	NULL
,	NULL
showed	NULL
a	NULL
rapid	NULL
kinetics	NULL
.	NULL

During	NULL
the	NULL
same	NULL
experimental	NULL
time	NULL
period	NULL
,	NULL
the	NULL
constitutively	NULL
expressed	NULL
nuclear	NULL
CCAAT-binding	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
remained	NULL
unchanged	NULL
with	NULL
either	NULL
PMA/ionomycin	NULL
or	NULL
IFN-y	NULL
treatment	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
mobility-shifted	NULL
complexes	NULL
was	NULL
confirmed	NULL
by	NULL
Ab	NULL
supershift	NULL
analysis	NULL
using	NULL
antiserum	NULL
specific	NULL
for	NULL
each	NULL
transcription	NULL
factor	NULL
subunit	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
transcription	NULL
factor	NULL
nuclear	NULL
import	NULL
by	NULL
a	NULL
cell-permeable	NULL
NLS	NULL
peptide	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
cell-permeable	NULL
peptide	NULL
carrying	NULL
the	NULL
NLS	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
SN50	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
blocks	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
endothelial	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Because	NULL
AP-1	NULL
and	NULL
NFAT	NULL
contain	NULL
NLSs	NULL
that	NULL
differ	NULL
from	NULL
the	NULL
p50	NULL
NLS	NULL
,	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
SsN50	NULL
(	NULL
M	NULL
)	NULL
:	NULL
-	NULL
PMA/lono	NULL
:	NULL
-	NULL
+	NULL
25	NULL
50	NULL
75	NULL
100	NULL
e	NULL
e	NULL
e	NULL
s	NULL
NF-	NULL
«	NULL
B8	NULL
[	NULL
y	NULL
Ar-1	NULL
[	NULL
mi	NULL
“	NULL
.	NULL

NH	NULL
=C	NULL
WM	NULL
Id	NULL
b	NULL
1	NULL
weat/ap-1	NULL
[	NULL
“	NULL
if	NULL
!	NULL

f	NULL
ne-v	NULL
[	NULL
SNS0	NULL
(	NULL
pM	NULL
)	NULL
:	NULL
-	NULL
IFNy	NULL
:	NULL
-	NULL
+	NULL
25	NULL
50	NULL
75	NULL
100	NULL
+	NULL
+	NULL
4+	NULL
+	NULL
1	NULL
1	NULL
1	NULL
1	NULL
I	NULL
srami	NULL
[	NULL
__	NULL
MAB	NULL
we	NULL
_	NULL
7	NULL
_L	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Concentration-dependent	NULL
inhibition	NULL
of	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
by	NULL
the	NULL
cell-permeable	NULL
SN5O	NULL
peptide	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
SN50	NULL
peptide	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
at	NULL
the	NULL
concentrations	NULL
indicated	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
5	NULL
nM	NULL
PMA/2	NULL
M	NULL
ionomycin	NULL
for	NULL
60	NULL
min	NULL
or	NULL
1	NULL
U/ml	NULL
IFN-y	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
transcription	NULL
factor	NULL
DNA-binding	NULL
activity	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
sections	NULL
of	NULL
autoradiograms	NULL
that	NULL
included	NULL
mobility-shifted	NULL
complexes	NULL
containing	NULL
the	NULL
specific	NULL
``	NULL
°P-labeled	NULL
DNA	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
STAT1	NULL
,	NULL
or	NULL
the	NULL
constitutively	NULL
expressed	NULL
nuclear	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

NS	NULL
underneath	NULL
STAT1	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
indicates	NULL
a	NULL
nonspecific	NULL
,	NULL
constitutive	NULL
band	NULL
.	NULL

fur-VI	NULL
:	NULL
4	NULL
and	NULL
the	NULL
STAT1	NULL
NLS	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
,	NULL
we	NULL
used	NULL
the	NULL
SN50	NULL
peptide	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
signal-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
same	NULL
NLS	NULL
peptide	NULL
that	NULL
blocked	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
SN50	NULL
peptide	NULL
inhibited	NULL
not	NULL
only	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
import	NULL
but	NULL
also	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
.	NULL

In	NULL
respect	NULL
to	NULL
NFAT	NULL
,	NULL
inhibition	NULL
was	NULL
observed	NULL
toward	NULL
both	NULL
its	NULL
forms	NULL
,	NULL
one	NULL
requiring	NULL
AP-1	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
detectable	NULL
with	NULL
human	NULL
DNA	NULL
probe	NULL
(	NULL
NFAT/AP-1	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
and	NULL
a	NULL
second	NULL
form	NULL
that	NULL
does	NULL
not	NULL
require	NULL
AP-1	NULL
complexation	NULL
for	NULL
binding	NULL
to	NULL
murine	NULL
DNA	NULL
probe	NULL
(	NULL
NFAT	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
activity	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
was	NULL
concentration-dependent	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
was	NULL
evident	NULL
for	NULL
up	NULL
to	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
time	NULL
frame	NULL
of	NULL
this	NULL
experiment	NULL
,	NULL
the	NULL
constitutively	NULL
expressed	NULL
NF-Y	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
SN50	NULL
peptide	NULL
.	NULL

Nevertheless	NULL
,	NULL
a	NULL
possibility	NULL
of	NULL
reduction	NULL
of	NULL
NF-Y	NULL
content	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
by	NULL
longer	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
SN50	NULL
peptide	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

6087	NULL
IFNyConcentration	NULL
(	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
-	NULL
1	NULL
100	NULL
SNS50	NULL
:	NULL
=	NULL
=	NULL
+	NULL
P	NULL
+	NULL
I_._I_|_I_I_I_.1	NULL
-3	NULL
.	NULL

%	NULL
2	NULL
~	NULL
C000	NULL
FIGURE	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
IFN-y	NULL
concentration	NULL
on	NULL
the	NULL
inhibition	NULL
of	NULL
STAT1	NULL
nuclear	NULL
import	NULL
by	NULL
the	NULL
cell-permeable	NULL
SN50	NULL
peptide	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
75	NULL
M	NULL
SN50	NULL
peptide	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
1	NULL
U/ml	NULL
or	NULL
100	NULL
U/ml	NULL
IFN-y	NULL
as	NULL
indicated	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
STAT1	NULL
and	NULL
NF-Y	NULL
DNA-binding	NULL
activity	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
sections	NULL
of	NULL
autoradiograms	NULL
that	NULL
included	NULL
mobility-shifted	NULL
complexes	NULL
containing	NULL
the	NULL
specific	NULL
*°P-labeled	NULL
DNA	NULL
and	NULL
STAT1	NULL
or	NULL
the	NULL
constituitively	NULL
expressed	NULL
nuclear	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

NS	NULL
underneath	NULL
STAT1	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
indicates	NULL
a	NULL
nonspecific	NULL
,	NULL
constitutive	NULL
band	NULL
.	NULL

sTaAT1	NULL
[	NULL
NS	NULL
C	NULL
We	NULL
found	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
to	NULL
inhibit	NULL
STAT1	NULL
nuclear	NULL
import	NULL
depends	NULL
on	NULL
the	NULL
concentration	NULL
of	NULL
IFN-y	NULL
used	NULL
to	NULL
stimulate	NULL
the	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
SN50	NULL
peptide	NULL
(	NULL
75	NULL
uM	NULL
)	NULL
efficiently	NULL
inhibited	NULL
STAT1	NULL
nuclear	NULL
import	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
a	NULL
low	NULL
dose	NULL
of	NULL
IFN-y	NULL
(	NULL
1	NULL
U/ml	NULL
)	NULL
,	NULL
but	NULL
this	NULL
inhibitory	NULL
effect	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
a	NULL
high	NULL
dose	NULL
of	NULL
IFN-y	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
STAT1	NULL
DNA-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
low	NULL
or	NULL
high	NULL
doses	NULL
of	NULL
IFN-y	NULL
were	NULL
similar	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
STAT1	NULL
DNA-binding	NULL
activity	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
low	NULL
and	NULL
high	NULL
doses	NULL
of	NULL
IFN-y	NULL
were	NULL
similar	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
loss	NULL
in	NULL
efficacy	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
at	NULL
high	NULL
doses	NULL
of	NULL
IFN-y	NULL
is	NULL
not	NULL
caused	NULL
by	NULL
an	NULL
increased	NULL
cytoplasmic	NULL
pool	NULL
of	NULL
activated	NULL
STAT1	NULL
saturating	NULL
the	NULL
peptide	NULL
inhibition	NULL
of	NULL
the	NULL
import	NULL
process	NULL
.	NULL

Because	NULL
stretches	NULL
of	NULL
basic	NULL
amino	NULL
acids	NULL
in	NULL
nucleic	NULL
acid-binding	NULL
proteins	NULL
sometimes	NULL
serve	NULL
as	NULL
both	NULL
the	NULL
NLS	NULL
and	NULL
the	NULL
DNA-	NULL
or	NULL
RNA-binding	NULL
domain	NULL
(	NULL
56	NULL
)	NULL
,	NULL
we	NULL
next	NULL
tested	NULL
whether	NULL
the	NULL
SN5O0	NULL
peptide	NULL
interfered	NULL
directly	NULL
with	NULL
in	NULL
vitro	NULL
DNA-binding	NULL
reactions	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
was	NULL
not	NULL
affected	NULL
when	NULL
SN50	NULL
peptide	NULL
(	NULL
20	NULL
uM	NULL
final	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
to	NULL
EMSA	NULL
reactions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
import	NULL
inhibition	NULL
by	NULL
the	NULL
SN5O	NULL
peptide	NULL
requires	NULL
the	NULL
NLS	NULL
motif	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
observed	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
nuclear	NULL
import	NULL
by	NULL
the	NULL
SN5O	NULL
peptide	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
p50	NULL
NLS	NULL
motif	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
cell-permeable	NULL
peptides	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
NLS	NULL
sequence	NULL
.	NULL

Fig	NULL
.	NULL

4A	NULL
shows	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
on	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
all	NULL
four	NULL
transcription	NULL
factors	NULL
was	NULL
significantly	NULL
reduced	NULL
when	NULL
only	NULL
2	NULL
of	NULL
10	NULL
NLS	NULL
residues	NULL
were	NULL
mutated	NULL
(	NULL
SN5OM	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
was	NULL
completely	NULL
lost	NULL
when	NULL
7	NULL
of	NULL
10	NULL
NLS	NULL
residues	NULL
were	NULL
mutated	NULL
(	NULL
SM	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
EMSA	NULL
results	NULL
,	NULL
Western	NULL
blots	NULL
were	NULL
performed	NULL
on	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
SN5O0	NULL
peptide	NULL
caused	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
intranuclear	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6088	NULL
&	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
if	NULL
?	NULL

git	NULL
?	NULL

54	NULL
“	NULL
?	NULL

eo	NULL
PMA/lono	NULL
:	NULL
-	NULL
4+	NULL
+	NULL
4+	NULL
+	NULL
+	NULL
wF-	NULL
«	NULL
B	NULL
[	NULL
__	NULL
__	NULL
ap-1	NULL
[	NULL
neat	NULL
[	NULL
Hug	NULL
“	NULL
=	NULL
<	NULL
0b	NULL
:	NULL
ne-¥y	NULL
[	NULL
&	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
&	NULL
$	NULL
&	NULL
a	NULL
IFNy	NULL
:	NULL
-o	NULL
o4+	NULL
0	NULL
40	NULL
+0	NULL
+	NULL
+	NULL
|_I_I_I_I——I—I—|	NULL
stati	NULL
[	NULL
6	NULL
i	NULL
4	NULL
«	NULL
o	NULL
com	NULL
to	NULL
ta	NULL
n	NULL
w	NULL
we-y	NULL
[	NULL
NUCLEAR	NULL
IMPORT	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
AND	NULL
STAT1I	NULL
B	NULL
&	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
@	NULL
q*	NULL
$	NULL
&	NULL
a	NULL
PMA/ono	NULL
:	NULL
-~	NULL
4+	NULL
+40	NULL
++	NULL
1	NULL
F	NULL
i	NULL
1	NULL
1	NULL
I	NULL
1	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
[	NULL
wm*	NULL
o=	NULL
:	NULL
W-	NULL
--	NULL
-	NULL
nrare	NULL
[	NULL
mun	NULL
UB	NULL
#	NULL
05	NULL
ans	NULL
wah	NULL
)	NULL
C	NULL
es	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
$	NULL
06	NULL
$	NULL
6	NULL
?	NULL

49	NULL
“	NULL
g	NULL
PMA/lono	NULL
:	NULL
-	NULL
+0	NULL
+0	NULL
40	NULL
++	NULL
'	NULL
_.I	NULL
...	NULL
.._I___I__I_—.J——|	NULL
ap-1	NULL
[	NULL
FIGURE	NULL
4	NULL
.	NULL

Nuclear	NULL
import	NULL
inhibition	NULL
by	NULL
SN5O	NULL
requires	NULL
the	NULL
NLS	NULL
motif	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
peptides	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
each	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
75	NULL
uM	NULL
,	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
5	NULL
nM	NULL
PMA/2	NULL
mM	NULL
ionomycin	NULL
for	NULL
60	NULL
min	NULL
or	NULL
1	NULL
U/ml	NULL
IFN-y	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
transcription	NULL
factor	NULL
DNA-binding	NULL
activity	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
sections	NULL
of	NULL
autoradiograms	NULL
that	NULL
included	NULL
mobility-shifted	NULL
complexes	NULL
containing	NULL
specific	NULL
°°P-labeled	NULL
DNA	NULL
and	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
STAT1	NULL
,	NULL
or	NULL
the	NULL
constitutively	NULL
expressed	NULL
nuclear	NULL
factor	NULL
,	NULL
NF-Y	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

NS	NULL
underneath	NULL
STAT1	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
indicates	NULL
a	NULL
nonspecific	NULL
,	NULL
constitutive	NULL
band	NULL
.	NULL

B	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
,	NULL
AP-1	NULL
c-Jun	NULL
subunit	NULL
,	NULL
and	NULL
NFATc	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
peptide-treated	NULL
cells	NULL
.	NULL

Extracts	NULL
used	NULL
in	NULL
this	NULL
analysis	NULL
were	NULL
the	NULL
same	NULL
as	NULL
those	NULL
used	NULL
for	NULL
EMSA	NULL
in	NULL
A	NULL
,	NULL
and	NULL
immunoblotting	NULL
was	NULL
done	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

C	NULL
,	NULL
Cytoplasmic	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
stimulated	NULL
as	NULL
in	NULL
A	NULL
and	NULL
assayed	NULL
for	NULL
AP-1	NULL
transcription	NULL
factor	NULL
DNA-binding	NULL
activity	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Material	NULL
and	NULL
Methods	NULL
.	NULL

Note	NULL
that	NULL
in	NULL
SN5O-treated	NULL
cells	NULL
there	NULL
is	NULL
a	NULL
partial	NULL
reduction	NULL
in	NULL
AP-1	NULL
DNA-binding	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
whereas	NULL
there	NULL
is	NULL
near	NULL
complete	NULL
inhibition	NULL
of	NULL
AP-1	NULL
nuclear	NULL
import	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
A	NULL
)	NULL
.	NULL

NFATc	NULL
proteins	NULL
.	NULL

The	NULL
mutant	NULL
peptide	NULL
,	NULL
SN5OM	NULL
,	NULL
was	NULL
much	NULL
less	NULL
effective	NULL
in	NULL
blocking	NULL
transcription	NULL
factor	NULL
nuclear	NULL
import	NULL
.	NULL

However	NULL
,	NULL
some	NULL
reduction	NULL
in	NULL
the	NULL
intranuclear	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
in	NULL
particular	NULL
NFATc	NULL
,	NULL
was	NULL
evident	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
SN5OM	NULL
peptide	NULL
and	NULL
this	NULL
result	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
reduction	NULL
in	NULL
the	NULL
DNA-binding	NULL
activities	NULL
observed	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
SM	NULL
peptide	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
intranuclear	NULL
levels	NULL
of	NULL
any	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
no	NULL
inhibitory	NULL
effect	NULL
was	NULL
seen	NULL
with	NULL
the	NULL
p50	NULL
NLS	NULL
peptide	NULL
lacking	NULL
the	NULL
cell-permeable	NULL
hydrophobic	NULL
sequence	NULL
(	NULL
N50	NULL
)	NULL
necessary	NULL
for	NULL
cellular	NULL
delivery	NULL
of	NULL
the	NULL
peptides	NULL
(	NULL
46	NULL
)	NULL
.	NULL

In	NULL
consideration	NULL
of	NULL
the	NULL
results	NULL
described	NULL
above	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
assess	NULL
whether	NULL
there	NULL
were	NULL
variations	NULL
in	NULL
the	NULL
cellular	NULL
uptake	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
NLS	NULL
peptides	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
relative	NULL
intracellular	NULL
peptide	NULL
concentrations	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
same	NULL
concentration	NULL
's	NULL
of	NULL
SN50	NULL
,	NULL
SNSOM	NULL
,	NULL
or	NULL
N50	NULL
(	NULL
75	NULL
M	NULL
)	NULL
using	NULL
quantitative	NULL
ELISA	NULL
.	NULL

Using	NULL
a	NULL
polyclonal	NULL
IgG	NULL
that	NULL
recognized	NULL
the	NULL
LMP	NULL
sequence	NULL
present	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
each	NULL
peptide	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
(	NULL
46	NULL
)	NULL
,	NULL
this	NULL
assay	NULL
demonstrated	NULL
that	NULL
both	NULL
cell-permeable	NULL
peptides	NULL
reached	NULL
an	NULL
intracellular	NULL
level	NULL
corresponding	NULL
to	NULL
approximately	NULL
4	NULL
%	NULL
of	NULL
the	NULL
total	NULL
peptide	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
non-cell-permeable	NULL
N50	NULL
peptide	NULL
was	NULL
not	NULL
detected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
AP-1	NULL
in	NULL
the	NULL
nucleus	NULL
following	NULL
cellular	NULL
activation	NULL
requires	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
SN5O	NULL
peptide	NULL
on	NULL
AP-1	NULL
nuclear	NULL
import	NULL
might	NULL
be	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
other	NULL
factors	NULL
necessary	NULL
for	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
possibility	NULL
by	NULL
measuring	NULL
the	NULL
level	NULL
of	NULL
AP-1	NULL
in	NULL
cytoplasmic	NULL
extracts	NULL
of	NULL
peptide-treated	NULL
and	NULL
control	NULL
cells	NULL
after	NULL
PMA/ionomycin	NULL
stimulation	NULL
.	NULL

As	NULL
determined	NULL
by	NULL
EMSAs	NULL
of	NULL
concentrated	NULL
cytoplasmic	NULL
extracts	NULL
,	NULL
cells	NULL
stimulated	NULL
for	NULL
60	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
5	NULL
.	NULL

Inhibition	NULL
of	NULL
IxBa	NULL
synthesis	NULL
by	NULL
6089	NULL
PMA/lonomycin	NULL
(	NULL
min	NULL
)	NULL
the	NULL
cell-permeable	NULL
SN50	NULL
peptide	NULL
.	NULL

A	NULL
,	NULL
A	NULL
section	NULL
I	NULL
of	NULL
a	NULL
Western	NULL
blot	NULL
that	NULL
demonstrates	NULL
the	NULL
kinetics	NULL
of	NULL
degradation	NULL
and	NULL
resynthesis	NULL
of	NULL
IxBa	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
with	NULL
5	NULL
nM	NULL
PMA/2	NULL
pM	NULL
ionomycin	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
by	NULL
immunoblotting	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
,	NULL
A	NULL
section	NULL
of	NULL
a	NULL
Western	NULL
blot	NULL
that	NULL
demonstrates	NULL
the	NULL
specific	NULL
inhibition	NULL
of	NULL
B	NULL
IxBa	NULL
resynthesis	NULL
by	NULL
the	NULL
SN5O0	NULL
peptide	NULL
following	NULL
agonist-induced	NULL
degradation	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
PMA/lono	NULL
:	NULL
0	NULL
1	NULL
i	NULL
I	NULL
iB	NULL
[	NULL
(	NULL
@	NULL
am	NULL
0	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
80	NULL
90I	NULL
1	NULL
1	NULL
i	NULL
i	NULL
i	NULL
i	NULL
i	NULL
i	NULL
i	NULL
i	NULL
20	NULL
min	NULL
90	NULL
min	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
peptides	NULL
(	NULL
see	NULL
I	NULL
Table	NULL
I	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
the	NULL
concentrations	NULL
Peptide	NULL
shown	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
5	NULL
nM	NULL
PMA/2	NULL
(	NULL
uM	NULL
)	NULL
nf	NULL
M	NULL
ionomycin	NULL
for	NULL
20	NULL
min	NULL
or	NULL
90	NULL
min	NULL
as	NULL
indi-	NULL
t	NULL
cated	NULL
.	NULL

Extract	NULL
preparation	NULL
and	NULL
analysis	NULL
was	NULL
the	NULL
same	NULL
as	NULL
in	NULL
A.	NULL
io	NULL
[	NULL
m	NULL
the	NULL
SN50	NULL
peptide	NULL
contained	NULL
approximately	NULL
60	NULL
%	NULL
AP-1	NULL
present	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
SN50	NULL
caused	NULL
near	NULL
complete	NULL
(	NULL
>	NULL
97	NULL
%	NULL
)	NULL
inhibition	NULL
of	NULL
AP-1	NULL
nuclear	NULL
import	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
SN5O	NULL
exerted	NULL
a	NULL
twofold	NULL
effect	NULL
on	NULL
AP-1	NULL
:	NULL
First	NULL
,	NULL
by	NULL
decreasing	NULL
the	NULL
amount	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
synthesized	NULL
and	NULL
second	NULL
,	NULL
by	NULL
inhibiting	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
subunits	NULL
that	NULL
are	NULL
synthesized	NULL
.	NULL

Inhibition	NULL
of	NULL
transcription	NULL
factor	NULL
nuclear	NULL
import	NULL
blocks	NULL
IxBa	NULL
and	NULL
IL-2	NULL
gene	NULL
expression	NULL
Because	NULL
the	NULL
induction	NULL
of	NULL
IxBa	NULL
gene	NULL
transcription	NULL
is	NULL
dependent	NULL
primarily	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
58-61	NULL
)	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
the	NULL
SN50	NULL
peptide	NULL
blocked	NULL
IxBa	NULL
expression	NULL
.	NULL

Fig	NULL
.	NULL

5A	NULL
shows	NULL
that	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
,	NULL
IxBa	NULL
was	NULL
rapidly	NULL
degraded	NULL
within	NULL
20	NULL
min	NULL
after	NULL
PMA/ionomycin	NULL
stimulation	NULL
and	NULL
that	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
IxBa	NULL
were	NULL
reestablished	NULL
after	NULL
90	NULL
min	NULL
due	NULL
to	NULL
its	NULL
rapid	NULL
de	NULL
novo	NULL
synthesis	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
SN5O	NULL
peptide	NULL
on	NULL
the	NULL
normal	NULL
process	NULL
of	NULL
IxBa	NULL
degradation	NULL
and	NULL
resynthesis	NULL
,	NULL
we	NULL
prepared	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
peptide-treated	NULL
and	NULL
control	NULL
cells	NULL
20	NULL
and	NULL
90	NULL
min	NULL
after	NULL
stimulation	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
I	NULL
«	NULL
xBa	NULL
degradation	NULL
proceeded	NULL
normally	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SN50	NULL
peptide	NULL
and	NULL
the	NULL
other	NULL
peptides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
extracellular	NULL
signal-induced	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
.	NULL

However	NULL
,	NULL
90	NULL
min	NULL
after	NULL
stimulation	NULL
a	NULL
concentration-dependent	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
on	NULL
IxBa	NULL
resynthesis	NULL
was	NULL
observed	NULL
,	NULL
while	NULL
neither	NULL
the	NULL
SM	NULL
nor	NULL
the	NULL
N50	NULL
control	NULL
peptide	NULL
significantly	NULL
inhibited	NULL
IxBa	NULL
resynthesis	NULL
.	NULL

Thus	NULL
,	NULL
inhibition	NULL
of	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
SN50	NULL
peptide	NULL
resulted	NULL
in	NULL
concomitant	NULL
inhibition	NULL
of	NULL
IxBa	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
depends	NULL
on	NULL
NF-B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
blockade	NULL
of	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
by	NULL
the	NULL
SN50	NULL
peptide	NULL
exerted	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
IL-2	NULL
gene	NULL
transcription	NULL
.	NULL

First	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
kinetics	NULL
of	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
peptide	NULL
.	NULL

Using	NULL
a	NULL
quantitative	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-2	NULL
mRNA	NULL
reached	NULL
easily	NULL
detectable	NULL
levels	NULL
after	NULL
90	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
PMA/ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
on	NULL
IL-2	NULL
mRNA	NULL
synthesis	NULL
90	NULL
min	NULL
after	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
SN50	NULL
peptide	NULL
caused	NULL
a	NULL
concentration-dependent	NULL
inhibition	NULL
of	NULL
inducible	NULL
IL-2	NULL
mRNA	NULL
synthesis	NULL
,	NULL
but	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
constitutive	NULL
synthesis	NULL
of	NULL
B-actin	NULL
mRNA	NULL
.	NULL

At	NULL
the	NULL
concentration	NULL
of	NULL
75	NULL
M	NULL
used	NULL
in	NULL
many	NULL
experiments	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
U	NULL
NSO	NULL
SNS5O	NULL
SM	NULL
-	NULL
75	NULL
150	NULL
75150	NULL
75150	NULL
NSO	NULL
sSNSO	NULL
SM	NULL
75	NULL
150	NULL
75150	NULL
75	NULL
150	NULL
I	NULL
IL-2	NULL
mRNA	NULL
synthesis	NULL
by	NULL
SN50	NULL
peptide	NULL
was	NULL
52	NULL
+	NULL
7.5	NULL
%	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
)	NULL
.	NULL

Interaction	NULL
of	NULL
inhibitory	NULL
SN50	NULL
peptide	NULL
with	NULL
cytoplasmic	NULL
NLS	NULL
receptor	NULL
complexes	NULL
Our	NULL
next	NULL
objective	NULL
was	NULL
to	NULL
determine	NULL
whether	NULL
inhibitory	NULL
NLS	NULL
peptide	NULL
interacts	NULL
with	NULL
the	NULL
known	NULL
cytoplasmic	NULL
NLS	NULL
receptor	NULL
complexes	NULL
expressed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

74	NULL
,	NULL
Reh1	NULL
and	NULL
importin-B	NULL
were	NULL
detected	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
extracts	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
purified	NULL
recombinant	NULL
Reh1	NULL
and	NULL
importin-	NULL
were	NULL
included	NULL
as	NULL
positive	NULL
controls	NULL
for	NULL
Ab	NULL
reactivity	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
Rceh1/importin-	NULL
complex	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
NLS	NULL
sequence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
NLS	NULL
peptide	NULL
,	NULL
in	NULL
vitro	NULL
binding	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
either	NULL
the	NULL
p50	NULL
wild-type	NULL
(	NULL
CYN350	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
CYN350	NULL
M	NULL
)	NULL
NLS	NULL
peptides	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
conjugated	NULL
to	NULL
biotinylated	NULL
BSA	NULL
.	NULL

To	NULL
capture	NULL
NLS	NULL
receptor	NULL
complexes	NULL
,	NULL
the	NULL
NLS	NULL
peptide/biotinylated-BSA	NULL
conjugates	NULL
were	NULL
incubated	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
sN50	NULL
(	NULL
M	NULL
)	NULL
:	NULL
-	NULL
-	NULL
25	NULL
50	NULL
75	NULL
100	NULL
PMA/lono	NULL
:	NULL
-	NULL
+0	NULL
+0	NULL
+0	NULL
++	NULL
h	NULL
;	NULL
l_L_	NULL
;	NULL
L._lﬁ	NULL
IL—ZE	NULL
!	NULL

Qé	NULL
«	NULL
tim	NULL
ugs	NULL
=	NULL
p-ncun	NULL
|	NULL
FIGURE	NULL
6	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-2	NULL
mRNA	NULL
synthesis	NULL
by	NULL
the	NULL
cell-permeable	NULL
SN50	NULL
peptide	NULL
.	NULL

Shown	NULL
is	NULL
an	NULL
autoradiogram	NULL
of	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
used	NULL
to	NULL
analyze	NULL
*°P-labeled	NULL
anti-sense	NULL
RNA	NULL
fragments	NULL
protected	NULL
from	NULL
RNase	NULL
A	NULL
and	NULL
T	NULL
,	NULL
digestion	NULL
by	NULL
IL-2	NULL
or	NULL
B-actin	NULL
mRNA	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
SN50	NULL
peptide	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
the	NULL
concentrations	NULL
indicated	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
5	NULL
nM	NULL
PMA/2	NULL
uM	NULL
ionomycin	NULL
for	NULL
90	NULL
min	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
IL-2	NULL
and	NULL
B-actin	NULL
transcripts	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6090	NULL
NUCLEAR	NULL
IMPORT	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
AND	NULL
STAT1I	NULL
A	NULL
B	NULL
NF-xB	NULL
p50	NULL
«	NULL
&	NULL
c	NULL
Fold	NULL
molar	NULL
Antibody	NULL
NLS/Peptide	NULL
$	NULL
9	NULL
excess	NULL
SN50	NULL
«	NULL
-Rehi	NULL
_	NULL
«	NULL
-Importin	NULL
mut	NULL
$	NULL
*	NULL
®	NULL
o	NULL
-	NULL
10	NULL
so	NULL
neem	NULL
||	NULL
fmol	NULL
o	NULL
--	NULL
--	NULL
-p	NULL
C	NULL
%	NULL
>	NULL
A	NULL
®	NULL
0	NULL
4	NULL
¢	NULL
p	NULL
y	NULL
t	NULL
'	NULL
Imp	NULL
-B	NULL
[	NULL
|	NULL
sas	NULL
imp	NULL
-	NULL
BC	NULL
_	NULL
mouth	NULL
jut	NULL
94	NULL
kD	NULL
-	NULL
--	NULL
eommam	NULL
»	NULL
Rcoh1	NULL
[	NULL
me-	NULL
@	NULL
a-	NULL
»	NULL
Rehi	NULL
C	NULL
w	NULL
67	NULL
kD	NULL
medics	NULL
43	NULL
kD	NULL
30	NULL
kD	NULL
FIGURE	NULL
7	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
nuclear	NULL
import	NULL
proteins	NULL
Reh1	NULL
and	NULL
importin-B	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
vitro	NULL
binding	NULL
to	NULL
NLS	NULL
peptides	NULL
.	NULL

A	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
Reh1	NULL
and	NULL
importin-	NULL
protein	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Blots	NULL
were	NULL
treated	NULL
with	NULL
Abs	NULL
to	NULL
Rch1	NULL
or	NULL
importin-	NULL
$	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
blot	NULL
.	NULL

Lanes	NULL
are	NULL
labeled	NULL
to	NULL
indicate	NULL
the	NULL
source	NULL
of	NULL
protein	NULL
as	NULL
either	NULL
the	NULL
specified	NULL
recombinant	NULL
protein	NULL
or	NULL
cell	NULL
extract	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
and	NULL
recombinant	NULL
proteins	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
by	NULL
immunoblotting	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
molecular	NULL
masses	NULL
of	NULL
protein	NULL
standards	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
kDa	NULL
.	NULL

B	NULL
,	NULL
Binding	NULL
of	NULL
Reh1	NULL
and	NULL
importin-	NULL
to	NULL
wild-type	NULL
and	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
NLS	NULL
peptides	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
wild-type	NULL
or	NULL
mutant	NULL
p50	NULL
NLS	NULL
peptides	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
that	NULL
were	NULL
conjugated	NULL
to	NULL
biotinylated	NULL
BSA	NULL
.	NULL

Proteins	NULL
bound	NULL
to	NULL
the	NULL
NLS	NULL
peptide/biotinylated-BSA	NULL
conjugate	NULL
were	NULL
recovered	NULL
using	NULL
streptavidin	NULL
beads	NULL
,	NULL
and	NULL
immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

C	NULL
,	NULL
Inhibition	NULL
by	NULL
SN50	NULL
peptide	NULL
of	NULL
Rch1/importin-6	NULL
binding	NULL
to	NULL
the	NULL
wild-type	NULL
NLS	NULL
peptide	NULL
conjugated	NULL
to	NULL
biotinylated	NULL
BSA	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
shows	NULL
that	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
free	NULL
(	NULL
unconjugated	NULL
)	NULL
SN50	NULL
peptide	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
Reh1/importin-	NULL
complex	NULL
to	NULL
the	NULL
homologous	NULL
NLS	NULL
peptide	NULL
conjugated	NULL
to	NULL
biotinylated	NULL
BSA	NULL
.	NULL

recovered	NULL
using	NULL
streptavidin	NULL
beads	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot-ting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
Reh1	NULL
and	NULL
importin-	NULL
interacted	NULL
with	NULL
the	NULL
wild-type	NULL
NLS	NULL
peptide/biotinylated-BSA	NULL
conjugate	NULL
.	NULL

The	NULL
reduction	NULL
of	NULL
Rch1	NULL
and	NULL
importin-B	NULL
binding	NULL
to	NULL
the	NULL
mutant	NULL
peptide/biotinylated-BSA	NULL
conjugate	NULL
indicates	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
interaction	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
residual	NULL
binding	NULL
of	NULL
Reh1	NULL
and	NULL
importin-f3	NULL
to	NULL
the	NULL
mutant	NULL
peptide	NULL
.	NULL

This	NULL
residual	NULL
binding	NULL
provides	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
transcription	NULL
factors	NULL
was	NULL
still	NULL
partially	NULL
inhibited	NULL
by	NULL
the	NULL
mutant	NULL
peptide	NULL
in	NULL
vivo	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7C	NULL
the	NULL
specificity	NULL
of	NULL
Reh1	NULL
and	NULL
importin-B	NULL
binding	NULL
to	NULL
the	NULL
wild-type	NULL
NLS	NULL
peptide/biotinylated-BSA	NULL
conjugate	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
this	NULL
interaction	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
used	NULL
in	NULL
experiments	NULL
performed	NULL
in	NULL
intact	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
inhibitory	NULL
SN50	NULL
peptide	NULL
targets	NULL
the	NULL
Rch	NULL
1/impor-tin-	NULL
}	NULL
NLS	NULL
receptor	NULL
complex	NULL
present	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
extracts	NULL
.	NULL

Discussion	NULL
It	NULL
is	NULL
well-recognized	NULL
that	NULL
signaling	NULL
to	NULL
the	NULL
nucleus	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
response	NULL
of	NULL
T	NULL
lymphocytes	NULL
to	NULL
immune	NULL
and	NULL
inflammatory	NULL
stimuli	NULL
.	NULL

The	NULL
steps	NULL
involved	NULL
in	NULL
this	NULL
signaling	NULL
include	NULL
:	NULL
1	NULL
)	NULL
antigenic	NULL
peptide-dependent	NULL
activation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
or	NULL
cyto-kine-dependent	NULL
activation	NULL
of	NULL
cognate	NULL
receptors	NULL
;	NULL
2	NULL
)	NULL
signal	NULL
transduc-tion	NULL
mediated	NULL
by	NULL
cytoplasmic	NULL
kinases	NULL
and	NULL
phosphatases	NULL
;	NULL
3	NULL
)	NULL
mobilization	NULL
of	NULL
various	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT	NULL
,	NULL
which	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
or	NULL
AP-1	NULL
following	NULL
its	NULL
de	NULL
novo	NULL
synthesis	NULL
;	NULL
4	NULL
)	NULL
import	NULL
of	NULL
transcription	NULL
factors	NULL
into	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
bind	NULL
to	NULL
DNA	NULL
and	NULL
activate	NULL
transcription	NULL
of	NULL
a	NULL
large	NULL
subset	NULL
of	NULL
genes	NULL
;	NULL
and	NULL
5	NULL
)	NULL
nucleocytoplasmic	NULL
export	NULL
of	NULL
some	NULL
transcription	NULL
factors	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
NFAT	NULL
.	NULL

Because	NULL
distinct	NULL
signal	NULL
transduc-tion	NULL
pathways	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
mobilization	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
agonist	NULL
stimulation	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
a	NULL
common	NULL
nuclear	NULL
import	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
involved	NULL
in	NULL
signaling	NULL
by	NULL
each	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
a	NULL
single	NULL
NLS	NULL
peptide	NULL
derived	NULL
from	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
delivered	NULL
noninvasively	NULL
to	NULL
the	NULL
cytoplasm	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
following	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
PMA/ionomycin	NULL
or	NULL
low	NULL
doses	NULL
of	NULL
IFN-y	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
is	NULL
inhibited	NULL
by	NULL
SN50	NULL
peptide	NULL
.	NULL

The	NULL
same	NULL
SN50	NULL
peptide	NULL
inhibited	NULL
the	NULL
stimulus-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
NF-KB	NULL
in	NULL
endothelial	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
SN50	NULL
peptide	NULL
containing	NULL
NLS	NULL
made	NULL
of	NULL
basic	NULL
amino	NULL
acids	NULL
is	NULL
unlikely	NULL
to	NULL
interfere	NULL
with	NULL
the	NULL
nuclear	NULL
export	NULL
of	NULL
NFAT	NULL
mediated	NULL
by	NULL
Ran	NULL
and	NULL
CRM1	NULL
(	NULL
63	NULL
)	NULL
and	NULL
enhanced	NULL
by	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
(	NULL
64	NULL
)	NULL
.	NULL

These	NULL
data	NULL
expand	NULL
the	NULL
range	NULL
of	NULL
inhibition	NULL
of	NULL
nuclear	NULL
import	NULL
by	NULL
SN50	NULL
peptide	NULL
to	NULL
three	NULL
other	NULL
transcription	NULL
factors	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
function	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Unlike	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
proteins	NULL
that	NULL
require	NULL
classical	NULL
or	NULL
bipartite	NULL
NLSs	NULL
for	NULL
nuclear	NULL
import	NULL
,	NULL
the	NULL
NFATp/c	NULL
proteins	NULL
can	NULL
be	NULL
efficiently	NULL
targeted	NULL
to	NULL
the	NULL
nucleus	NULL
by	NULL
a	NULL
short	NULL
sequence	NULL
having	NULL
only	NULL
three	NULL
basic	NULL
residues	NULL
(	NULL
KRR	NULL
or	NULL
KRK	NULL
)	NULL
located	NULL
in	NULL
the	NULL
amino-terminal	NULL
segment	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Cal-cineurin-mediated	NULL
dephosphorylation	NULL
of	NULL
nearby	NULL
serine	NULL
residues	NULL
is	NULL
postulated	NULL
to	NULL
expose	NULL
this	NULL
region	NULL
for	NULL
binding	NULL
by	NULL
the	NULL
nuclear	NULL
import	NULL
machinery	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
required	NULL
for	NULL
activation-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
STAT1	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
but	NULL
inspection	NULL
of	NULL
the	NULL
STAT1	NULL
amino	NULL
acid	NULL
sequence	NULL
(	NULL
65	NULL
)	NULL
reveals	NULL
three	NULL
clusters	NULL
of	NULL
basic	NULL
amino	NULL
acid	NULL
residues	NULL
that	NULL
have	NULL
been	NULL
postulated	NULL
to	NULL
function	NULL
as	NULL
NLSs	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
deletion	NULL
and	NULL
mutagenesis	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
none	NULL
of	NULL
these	NULL
sequences	NULL
serve	NULL
as	NULL
the	NULL
NLS	NULL
of	NULL
STAT1	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
a	NULL
unique	NULL
type	NULL
of	NULL
NLS	NULL
is	NULL
present	NULL
within	NULL
this	NULL
protein	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
SN50	NULL
peptide	NULL
efficiently	NULL
inhibited	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
STAT1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
low	NULL
doses	NULL
of	NULL
IFN-y	NULL
,	NULL
but	NULL
with	NULL
high	NULL
doses	NULL
this	NULL
inhibitory	NULL
effect	NULL
was	NULL
significantly	NULL
decreased	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
SN50	NULL
peptide	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
nuclear	NULL
import	NULL
does	NULL
not	NULL
change	NULL
even	NULL
when	NULL
a	NULL
20-fold	NULL
higher	NULL
concentration	NULL
of	NULL
agonist	NULL
PMA	NULL
,	NULL
in	NULL
combination	NULL
with	NULL
ionomycin	NULL
,	NULL
is	NULL
used	NULL
to	NULL
stimulate	NULL
the	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
levels	NULL
of	NULL
activated	NULL
STAT	NULL
1	NULL
in	NULL
both	NULL
nuclear	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
significantly	NULL
different	NULL
at	NULL
low	NULL
and	NULL
high	NULL
doses	NULL
of	NULL
IFN-y	NULL
,	NULL
the	NULL
insensitivity	NULL
of	NULL
STAT1	NULL
nuclear	NULL
import	NULL
to	NULL
inhibition	NULL
by	NULL
the	NULL
p50	NULL
NLS	NULL
peptide	NULL
at	NULL
high	NULL
doses	NULL
of	NULL
this	NULL
cytokine	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
simply	NULL
a	NULL
consequence	NULL
of	NULL
increased	NULL
cytoplasmic	NULL
pools	NULL
of	NULL
activated	NULL
STAT1	NULL
overcoming	NULL
peptide	NULL
inhibition	NULL
of	NULL
the	NULL
import	NULL
process	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
in	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
expressing	NULL
much	NULL
higher	NULL
concentration	NULL
of	NULL
STAT1	NULL
that	NULL
at	NULL
both	NULL
low	NULL
and	NULL
high	NULL
doses	NULL
of	NULL
IFN-y	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
occurs	NULL
normally	NULL
and	NULL
is	NULL
unaffected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
,	NULL
thereby	NULL
demonstrating	NULL
that	NULL
SN50	NULL
's	NULL
effect	NULL
on	NULL
STAT1	NULL
is	NULL
not	NULL
at	NULL
the	NULL
level	NULL
of	NULL
signal	NULL
trans-duction	NULL
(	NULL
T.R.T	NULL
.	NULL

and	NULL
J.H	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
there	NULL
are	NULL
biochemical	NULL
differences	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
STAT1	NULL
nuclear	NULL
import	NULL
that	NULL
depend	NULL
on	NULL
the	NULL
concentration	NULL
of	NULL
IFN-y	NULL
and	NULL
that	NULL
an	NULL
alternative	NULL
import	NULL
pathway	NULL
,	NULL
resistant	NULL
to	NULL
inhibition	NULL
by	NULL
a	NULL
classical	NULL
NLS	NULL
peptide	NULL
,	NULL
is	NULL
used	NULL
at	NULL
higher	NULL
concentrations	NULL
.	NULL

In	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
HeLa	NULL
and	NULL
293T	NULL
)	NULL
,	NULL
high	NULL
concentrations	NULL
of	NULL
IFN-y	NULL
(	NULL
>	NULL
2000	NULL
U/ml	NULL
!	NULL
)	NULL

induced	NULL
nuclear	NULL
import	NULL
of	NULL
STAT1	NULL
mediated	NULL
by	NULL
NPI-1	NULL
(	NULL
hSRP1	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
NLS	NULL
peptides	NULL
derived	NULL
from	NULL
wild-type	NULL
SV40	NULL
T	NULL
Ag	NULL
did	NULL
not	NULL
inhibit	NULL
interaction	NULL
between	NULL
NPI-1	NULL
and	NULL
STAT1	NULL
(	NULL
32	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
our	NULL
findings	NULL
that	NULL
high	NULL
doses	NULL
of	NULL
IFN-y	NULL
induce	NULL
nuclear	NULL
import	NULL
of	NULL
STAT1	NULL
that	NULL
is	NULL
insensitive	NULL
to	NULL
inhibition	NULL
by	NULL
NLS	NULL
peptide	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
transportin	NULL
(	NULL
karyopherin-	NULL
;	NULL
)	NULL
in	NULL
this	NULL
alternative	NULL
pathway	NULL
seems	NULL
unlikely	NULL
because	NULL
there	NULL
are	NULL
no	NULL
regions	NULL
within	NULL
STAT1	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
M9	NULL
sequence	NULL
of	NULL
hnRNP	NULL
A1	NULL
and	NULL
transportin	NULL
pathway	NULL
is	NULL
not	NULL
sensitive	NULL
to	NULL
inhibition	NULL
by	NULL
peptides	NULL
representing	NULL
classical	NULL
NLS	NULL
sequences	NULL
(	NULL
43	NULL
,	NULL
44	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
nuclear	NULL
import	NULL
of	NULL
STAT1	NULL
requires	NULL
IFN-y-induced	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
701	NULL
,	NULL
dimerization	NULL
of	NULL
the	NULL
subunits	NULL
,	NULL
and	NULL
the	NULL
GTPase	NULL
activity	NULL
of	NULL
Ran/TC4	NULL
(	NULL
66	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
is	NULL
needed	NULL
for	NULL
translocation	NULL
of	NULL
karyophilic	NULL
proteins	NULL
across	NULL
the	NULL
nuclear	NULL
pore	NULL
following	NULL
their	NULL
recognition	NULL
and	NULL
docking	NULL
by	NULL
either	NULL
impor-tin-wB	NULL
(	NULL
karyopherin-	NULL
«	NULL
fB	NULL
,	NULL
)	NULL
or	NULL
transportin	NULL
(	NULL
karyopherin-B	NULL
,	NULL
)	NULL
NLS	NULL
receptors	NULL
(	NULL
43	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
an	NULL
inhibitory	NULL
SN50	NULL
peptide	NULL
containing	NULL
the	NULL
NLS	NULL
of	NULL
NF-KB	NULL
p50	NULL
(	NULL
SN50	NULL
)	NULL
binds	NULL
to	NULL
the	NULL
Rch1	NULL
(	NULL
importin-a	NULL
@	NULL
)	NULL
/importin-f	NULL
het-erodimer	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
NLS	NULL
because	NULL
mutation	NULL
of	NULL
two	NULL
basic	NULL
amino	NULL
acid	NULL
residues	NULL
within	NULL
the	NULL
sequence	NULL
significantly	NULL
reduces	NULL
binding	NULL
of	NULL
the	NULL
peptide	NULL
to	NULL
Reh1	NULL
and	NULL
importin-B	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
p50	NULL
NLS	NULL
peptide	NULL
inhibits	NULL
nuclear	NULL
import	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT1	NULL
involves	NULL
direct	NULL
disruption	NULL
or	NULL
blockade	NULL
of	NULL
the	NULL
importin-af3-transcription	NULL
factor	NULL
interaction	NULL
.	NULL

Because	NULL
Rceh1	NULL
contains	NULL
the	NULL
NLS-binding	NULL
domain	NULL
(	NULL
67	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
p50	NULL
NLS	NULL
peptide	NULL
binds	NULL
directly	NULL
to	NULL
this	NULL
subunit	NULL
of	NULL
the	NULL
importin-aB	NULL
complex	NULL
,	NULL
an	NULL
interpretation	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
SN50	NULL
peptide	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
binds	NULL
recombinant	NULL
Rceh1	NULL
but	NULL
not	NULL
importin-	NULL
in	NULL
vitro	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
NLS	NULL
peptides	NULL
derived	NULL
from	NULL
different	NULL
karyophilic	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
varies	NULL
in	NULL
respect	NULL
to	NULL
different	NULL
importin-	NULL
«	NULL
(	NULL
karyopherin-	NULL
«	NULL
)	NULL
proteins	NULL
(	NULL
68	NULL
)	NULL
.	NULL

It	NULL
is	NULL
plausible	NULL
that	NULL
more	NULL
than	NULL
one	NULL
importin-	NULL
«	NULL
(	NULL
karyopherin-a	NULL
)	NULL
protein	NULL
interacts	NULL
with	NULL
transcription	NULL
factors	NULL
analyzed	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
more	NULL
than	NULL
one	NULL
transcription	NULL
factors	NULL
by	NULL
SN50	NULL
peptide	NULL
as	NULL
reported	NULL
herein	NULL
has	NULL
practical	NULL
implications	NULL
in	NULL
view	NULL
of	NULL
growing	NULL
use	NULL
of	NULL
this	NULL
reagent	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
(	NULL
69	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Interpretation	NULL
of	NULL
these	NULL
data	NULL
should	NULL
take	NULL
into	NULL
account	NULL
the	NULL
expanded	NULL
range	NULL
of	NULL
SN50	NULL
peptide	NULL
inhibitory	NULL
activity	NULL
toward	NULL
nuclear	NULL
import	NULL
of	NULL
transcription	NULL
factors	NULL
other	NULL
than	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
SN50	NULL
peptide	NULL
also	NULL
inhibited	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IxBa	NULL
and	NULL
IL-2	NULL
genes	NULL
,	NULL
processes	NULL
dependent	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
alone	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
(	NULL
58-62	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
IxBa	NULL
(	NULL
MAD3	NULL
)	NULL
gene	NULL
regulated	NULL
primarily	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
expression	NULL
of	NULL
IL-2	NULL
requires	NULL
complex	NULL
synergy	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
and	NULL
can	NULL
proceed	NULL
when	NULL
relatively	NULL
low	NULL
con	NULL
6091	NULL
centrations	NULL
of	NULL
these	NULL
factors	NULL
along	NULL
with	NULL
constitutively	NULL
nuclear	NULL
factors	NULL
are	NULL
attained	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Thus	NULL
,	NULL
partial	NULL
inhibition	NULL
of	NULL
nuclear	NULL
import	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
by	NULL
the	NULL
SN50	NULL
peptide	NULL
at	NULL
50	NULL
uM	NULL
was	NULL
apparently	NULL
insufficient	NULL
to	NULL
cause	NULL
significant	NULL
inhibition	NULL
of	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
.	NULL

Higher	NULL
concentrations	NULL
of	NULL
the	NULL
SN50	NULL
peptide	NULL
(	NULL
75-100	NULL
wM	NULL
)	NULL
are	NULL
required	NULL
to	NULL
achieve	NULL
>	NULL
50	NULL
%	NULL
inhibition	NULL
of	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
at	NULL
90	NULL
min	NULL
following	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
,	NULL
to	NULL
our	NULL
knowledge	NULL
,	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
gene	NULL
expression	NULL
can	NULL
be	NULL
regulated	NULL
in	NULL
intact	NULL
cells	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
transcription	NULL
factor	NULL
nuclear	NULL
import	NULL
at	NULL
the	NULL
level	NULL
of	NULL
NLS	NULL
recognition	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
significant	NULL
because	NULL
they	NULL
offer	NULL
a	NULL
new	NULL
strategy	NULL
to	NULL
exert	NULL
an	NULL
immunosuppressive	NULL
effect	NULL
on	NULL
intact	NULL
,	NULL
activated	NULL
T	NULL
cells	NULL
through	NULL
blockading	NULL
nuclear	NULL
import	NULL
of	NULL
key	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
immune	NULL
function	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

D.	NULL
Ballard	NULL
and	NULL
M.	NULL
Boothby	NULL
for	NULL
valuable	NULL
discussions	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

Reagents	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

C.	NULL
Benoist	NULL
,	NULL
M.	NULL
Boothby	NULL
,	NULL
G.	NULL
Crabtree	NULL
,	NULL
D.	NULL
Gérlich	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
S.	NULL
Hann	NULL
,	NULL
Y.	NULL
Liu	NULL
,	NULL
R.	NULL
Mantovani	NULL
,	NULL
D.	NULL
Mathis	NULL
,	NULL
G.	NULL
Miller	NULL
,	NULL
and	NULL
P.	NULL
Palese	NULL
.	NULL

The	NULL
editorial	NULL
assistance	NULL
of	NULL
Carol	NULL
Walter	NULL
and	NULL
Traci	NULL
Castleman	NULL
in	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
is	NULL
gratefully	NULL
acknowledged	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045	NULL
.	NULL

2	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
J.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
responses	NULL
to	NULL
polypeptide	NULL
ligands	NULL
:	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621	NULL
.	NULL

3	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1240	NULL
.	NULL

4	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727	NULL
.	NULL

5	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IKB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-KB	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

[	NULL
Published	NULL
erratum	NULL
appears	NULL
in	NULL
1992	NULL
Genes	NULL
Dev	NULL
.	NULL

6:2664	NULL
.	NULL
]	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899	NULL
.	NULL

6	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
M.	NULL
d.	NULL
S.	NULL
Silva	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

Nuclear	NULL
uptake	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
MAD-3	NULL
,	NULL
an	NULL
I	NULL
«	NULL
B	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:201	NULL
.	NULL

7	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.	NULL
C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

Ix	NULL
B/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-kB	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transacti-vation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339	NULL
.	NULL

8	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
Donald	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Read	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1993	NULL
.	NULL

Lipopolysaccharide	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAD3	NULL
and	NULL
activation	NULL
of	NULL
c-Rel	NULL
and	NULL
related	NULL
NF-KB	NULL
proteins	NULL
in	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:11803	NULL
.	NULL

9	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
IkBa	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586	NULL
.	NULL

10	NULL
.	NULL

Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
requires	NULL
site-specific	NULL
ubiquitination	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11259	NULL
.	NULL

11	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
O.	NULL
J.	NULL
Rando	NULL
,	NULL
A.	NULL
L.	NULL
Goldberg	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-KB1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-B	NULL
.	NULL

Cell	NULL
78:773	NULL
.	NULL

12	NULL
.	NULL

Donald	NULL
,	NULL
R.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1995	NULL
.	NULL

Proteolytic	NULL
processing	NULL
of	NULL
NF-B/IKB	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

ATP-dependent	NULL
induction	NULL
by	NULL
pro-inflammatory	NULL
mediators	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:9	NULL
.	NULL

13	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352	NULL
.	NULL

14	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
R.	NULL
Yaseen	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATp	NULL
inhibits	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
cyclosporin	NULL
A-treated	NULL
human	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:20653	NULL
.	NULL

15	NULL
.	NULL

Ruff	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Leach	NULL
.	NULL

1995	NULL
.	NULL

Direct	NULL
demonstration	NULL
of	NULL
NFATp	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
localization	NULL
in	NULL
activated	NULL
HT-2	NULL
cells	NULL
using	NULL
a	NULL
specific	NULL
NFATp	NULL
polyclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:22602	NULL
.	NULL

16	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
C.	NULL
Y.	NULL
Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911	NULL
.	NULL

17	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917	NULL
.	NULL

18	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Z	NULL
.	NULL

Miner	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
preexisting	NULL
and	NULL
nuclear	NULL
forms	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:837	NULL
.	NULL

19	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
V.	NULL
R.	NULL
Prezioso	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
J.	NULL
Darnell	NULL
.	NULL

1992	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
IFN-y	NULL
:	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
91-kDa	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
258:1808	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
6092	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
J.	NULL
Damell	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
single	NULL
phospho-tyrisine	NULL
residue	NULL
of	NULL
Stat91	NULL
required	NULL
for	NULL
gene	NULL
activation	NULL
by	NULL
interferon-y	NULL
.	NULL

Science	NULL
261:1744	NULL
.	NULL

Roux	NULL
,	NULL
P.	NULL
,	NULL
J.-M.	NULL
Blanchard	NULL
,	NULL
A.	NULL
Fernandez	NULL
,	NULL
N.	NULL
Lamb	NULL
,	NULL
P.	NULL
Jeanteur	NULL
,	NULL
and	NULL
M.	NULL
Piechaczyk	NULL
.	NULL

1990	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
c-Fos	NULL
,	NULL
but	NULL
not	NULL
v-Fos	NULL
proteins	NULL
,	NULL
is	NULL
controlled	NULL
by	NULL
extracellular	NULL
signals	NULL
.	NULL

Cell	NULL
63:341	NULL
.	NULL

Gorlich	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
I.	NULL
W.	NULL
Mattaj	NULL
.	NULL

1996	NULL
.	NULL

Nucleocytoplasmic	NULL
transport	NULL
.	NULL

Science	NULL
271	NULL
:	NULL
1513	NULL
.	NULL

Dingwall	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Laskey	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
targeting	NULL
sequences-a	NULL
consen-sus	NULL
?	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16:478	NULL
.	NULL

Boulikas	NULL
,	NULL
T.	NULL
1993	NULL
.	NULL

Nuclear	NULL
localization	NULL
signals	NULL
(	NULL
NLS	NULL
)	NULL
.	NULL

Crif	NULL
.	NULL

Rev	NULL
.	NULL

Eukaryotic	NULL
.	NULL

Gene	NULL
Exp	NULL
.	NULL

3:193	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1991	NULL
.	NULL

Cytoplasmic	NULL
retention	NULL
,	NULL
DNA	NULL
binding	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
precursor	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
small	NULL
region	NULL
in	NULL
its	NULL
C-terminus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:4159	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
U.	NULL
Zabel	NULL
,	NULL
K.	NULL
v.	NULL
Zee	NULL
,	NULL
J.	NULL
M.	NULL
Muller	NULL
,	NULL
E.	NULL
Fanning	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1992	NULL
.	NULL

Intramolecular	NULL
masking	NULL
of	NULL
the	NULL
nuclear	NULL
location	NULL
signal	NULL
and	NULL
dimerization	NULL
domain	NULL
in	NULL
the	NULL
precursor	NULL
for	NULL
the	NULL
p50	NULL
NF-kB	NULL
subunit	NULL
.	NULL

Cell	NULL
68:1121	NULL
.	NULL

Tratner	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
nuclear	NULL
targeting	NULL
sequence	NULL
in	NULL
the	NULL
Fos	NULL
protein	NULL
.	NULL

Oncogene	NULL
6:2049	NULL
.	NULL

Chida	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
P.	NULL
K.	NULL
Vogt	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
viral	NULL
Jun	NULL
but	NULL
not	NULL
of	NULL
cellular	NULL
Jun	NULL
is	NULL
cell	NULL
cycle	NULL
dependent	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4290	NULL
.	NULL

Mikaelian	NULL
,	NULL
I.	NULL
,	NULL
E.	NULL
Drouct	NULL
,	NULL
V.	NULL
Marechal	NULL
,	NULL
G.	NULL
Denoyel	NULL
,	NULL
J.	NULL
C.	NULL
Nicolas	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
DNA-binding	NULL
domain	NULL
of	NULL
two	NULL
bZIP	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
switch	NULL
gene	NULL
product	NULL
EB1	NULL
and	NULL
Jun	NULL
,	NULL
is	NULL
a	NULL
bipartite	NULL
nuclear	NULL
targeting	NULL
sequence	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:734	NULL
.	NULL

Beals	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
N.	NULL
A.	NULL
Clipstone	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
NF-ATc	NULL
by	NULL
a	NULL
calcineurin-dependent	NULL
,	NULL
cyclosporin-sensitive	NULL
intramolecular	NULL
interaction	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:824	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
K.	NULL
T.	NULL
Shaw	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Aramburu	NULL
,	NULL
F.	NULL
Garcia-Cozar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Perrino	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Interaction	NULL
of	NULL
calcineurin	NULL
with	NULL
a	NULL
domain	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
that	NULL
controls	NULL
nuclear	NULL
import	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:8907	NULL
.	NULL

Sekimoto	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Imamoto	NULL
,	NULL
K.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
Y.	NULL
Yoneda	NULL
.	NULL

1997	NULL
.	NULL

Extracellular	NULL
signal-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
Statl	NULL
is	NULL
mediated	NULL
by	NULL
nuclear	NULL
pore-targeting	NULL
complex	NULL
formation	NULL
with	NULL
NPI-1	NULL
,	NULL
but	NULL
not	NULL
Rch1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:7067	NULL
.	NULL

Cuomo	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
S.	NULL
A.	NULL
Kirch	NULL
,	NULL
J.	NULL
Gyuris	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Oettinger	NULL
.	NULL

1994	NULL
.	NULL

Rch1	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
specifically	NULL
interacts	NULL
with	NULL
the	NULL
RAG-1	NULL
recombination-activating	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:6156	NULL
.	NULL

Weis	NULL
,	NULL
K.	NULL
,	NULL
I.	NULL
W.	NULL
Maitaj	NULL
,	NULL
and	NULL
A.	NULL
I.	NULL
Lamond	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
hSRP1a	NULL
@	NULL
as	NULL
a	NULL
functional	NULL
receptor	NULL
for	NULL
nuclear	NULL
localization	NULL
sequences	NULL
.	NULL

Science	NULL
268:1049	NULL
.	NULL

Cortes	NULL
,	NULL
P.	NULL
,	NULL
Z.	NULL
S.	NULL
Ye	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1994	NULL
.	NULL

RAG-1	NULL
interacts	NULL
with	NULL
the	NULL
repeated	NULL
amino	NULL
acid	NULL
motif	NULL
of	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
yeast	NULL
protein	NULL
SRP1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:7633	NULL
.	NULL

O'Neill	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
P.	NULL
Palese	NULL
.	NULL

1995	NULL
.	NULL

NPI-1	NULL
,	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
SRP-1	NULL
,	NULL
interacts	NULL
with	NULL
influenza	NULL
virus	NULL
nucleoprotein	NULL
.	NULL

Virology	NULL
206:116	NULL
.	NULL

Nachury	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
U.	NULL
W.	NULL
Ryder	NULL
,	NULL
A.	NULL
I.	NULL
Lamond	NULL
,	NULL
and	NULL
K.	NULL
Weis	NULL
.	NULL

1998	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
hSRP1y	NULL
,	NULL
a	NULL
tissue-specific	NULL
nuclear	NULL
transport	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:582	NULL
.	NULL

Kohler	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Ansicau	NULL
,	NULL
S.	NULL
Prehn	NULL
,	NULL
A.	NULL
Leutz	NULL
,	NULL
H.	NULL
Haller	NULL
,	NULL
and	NULL
E.	NULL
Hartmann	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
of	NULL
two	NULL
novel	NULL
human	NULL
importin-a	NULL
subunits	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
importin-a	NULL
protein	NULL
family	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

417:104	NULL
.	NULL

Tsuji	NULL
,	NULL
L.	NULL
,	NULL
T.	NULL
Takumi	NULL
,	NULL
N.	NULL
Imamoto	NULL
,	NULL
and	NULL
Y.	NULL
Yoneda	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
of	NULL
novel	NULL
homologues	NULL
of	NULL
mouse	NULL
importin	NULL
a	NULL
,	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
nuclear	NULL
pore-targeting	NULL
complex	NULL
,	NULL
and	NULL
their	NULL
tissue-specific	NULL
expression	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

416:30	NULL
.	NULL

Seki	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Tada	NULL
,	NULL
T.	NULL
Katada	NULL
,	NULL
and	NULL
T.	NULL
Enomoto	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
novel	NULL
importin-a	NULL
homologue	NULL
,	NULL
Qip1	NULL
:	NULL
discrimination	NULL
of	NULL
Qipl	NULL
and	NULL
Rch1	NULL
from	NULL
hSrpl	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
DNA	NULL
helicase	NULL
QURecQL	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

234:48	NULL
.	NULL

Gorlich	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Kostka	NULL
,	NULL
R.	NULL
Kraft	NULL
,	NULL
C.	NULL
Dingwall	NULL
,	NULL
R.	NULL
A.	NULL
Laskey	NULL
,	NULL
E.	NULL
Hartmann	NULL
,	NULL
and	NULL
S.	NULL
Prehn	NULL
.	NULL

1995	NULL
.	NULL

Two	NULL
different	NULL
subunits	NULL
of	NULL
importin	NULL
cooperate	NULL
to	NULL
recognize	NULL
nuclear	NULL
localization	NULL
signals	NULL
and	NULL
bind	NULL
them	NULL
to	NULL
the	NULL
nuclear	NULL
envelope	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

5:383	NULL
.	NULL

Chi	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
E.	NULL
J.	NULL
Adam	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Adam	NULL
.	NULL

1995	NULL
.	NULL

Sequence	NULL
and	NULL
characterization	NULL
of	NULL
cytoplasmic	NULL
nuclear	NULL
protein	NULL
import	NULL
factor	NULL
p97	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

130:265	NULL
.	NULL

Bonifaci	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Moroianu	NULL
,	NULL
A.	NULL
Radu	NULL
,	NULL
and	NULL
G.	NULL
Blobel	NULL
.	NULL

1997	NULL
.	NULL

Karyopherin	NULL
B2	NULL
mediates	NULL
nuclear	NULL
import	NULL
of	NULL
a	NULL
mRNA	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:5055	NULL
.	NULL

Pollard	NULL
,	NULL
V.	NULL
W.	NULL
,	NULL
W.	NULL
M.	NULL
Michael	NULL
,	NULL
S.	NULL
Nakielny	NULL
,	NULL
M.	NULL
C.	NULL
Siomi	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
G.	NULL
Dreyfuss	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
novel	NULL
receptor-mediated	NULL
nuclear	NULL
protein	NULL
import	NULL
pathway	NULL
.	NULL

Cell	NULL
86:985	NULL
.	NULL

Aitchison	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
G.	NULL
Blobel	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Rout	NULL
.	NULL

1996	NULL
.	NULL

Kap1Q4p	NULL
:	NULL
a	NULL
karyopherin	NULL
involved	NULL
in	NULL
the	NULL
nuclear	NULL
transport	NULL
of	NULL
messenger	NULL
RNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
274:624	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

NUCLEAR	NULL
IMPORT	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
AND	NULL
STAT1I	NULL
Lin	NULL
,	NULL
Y.-Z	NULL
.	NULL

,	NULL
S.	NULL
Y.	NULL
Yao	NULL
,	NULL
R.	NULL
A.	NULL
Veach	NULL
,	NULL
T.	NULL
R.	NULL
Torgerson	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
synthetic	NULL
peptide	NULL
containing	NULL
a	NULL
cell	NULL
membrane-permeable	NULL
motif	NULL
and	NULL
nuclear	NULL
localization	NULL
sequence	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14255	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
:	NULL
6419	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
J.	NULL
J.	NULL
Lucas	NULL
,	NULL
E.	NULL
Sibley	NULL
,	NULL
M.	NULL
A.	NULL
Bolanowski	NULL
,	NULL
R.	NULL
J.	NULL
Christy	NULL
,	NULL
T.	NULL
J.	NULL
Kelly	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Lane	NULL
.	NULL

1988	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
differentiation-induced	NULL
gene	NULL
for	NULL
fatty	NULL
acid-binding	NULL
protein	NULL
is	NULL
activated	NULL
by	NULL
glucocorticoid	NULL
and	NULL
cAMP	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:2949	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:625	NULL
.	NULL

Wagner	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
T.	NULL
E.	NULL
Hayes	NULL
,	NULL
C.	NULL
J.	NULL
Hoban	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Cochran	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
SIF	NULL
binding	NULL
element	NULL
confers	NULL
sis/PDGF	NULL
inducibility	NULL
onto	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:4477	NULL
.	NULL

Boothby	NULL
,	NULL
M.	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1989	NULL
.	NULL

Differences	NULL
in	NULL
DNA	NULL
sequence	NULL
specificity	NULL
among	NULL
MHC	NULL
class	NULL
II	NULL
X	NULL
box	NULL
binding	NULL
proteins	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142	NULL
;	NULL
:1005	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
227:680	NULL
.	NULL

Gorlich	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Prehn	NULL
,	NULL
R.	NULL
A.	NULL
Laskey	NULL
,	NULL
and	NULL
E.	NULL
Hartmann	NULL
.	NULL

1994	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
protein	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
first	NULL
step	NULL
of	NULL
nuclear	NULL
protein	NULL
import	NULL
.	NULL

Cell	NULL
79:767	NULL
.	NULL

Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
1992	NULL
.	NULL

Costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
:	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
,	NULL
CTLA-4	NULL
,	NULL
and	NULL
B7/BB1	NULL
in	NULL
interleukin-2	NULL
production	NULL
and	NULL
immunotherapy	NULL
.	NULL

Cell	NULL
77	NULL
:	NULL
1065	NULL
.	NULL

LaCasse	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Y	NULL
.	NULL

A.	NULL
Lefebvre	NULL
.	NULL

1995	NULL
.	NULL

Nuclear	NULL
localization	NULL
signals	NULL
overlap	NULL
DNA-	NULL
or	NULL
RNA-binding	NULL
domains	NULL
in	NULL
nucleic	NULL
acid-binding	NULL
proteins	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:1647	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:129	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-kB	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IkB-a	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532	NULL
.	NULL

Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
of	NULL
NF-KB	NULL
regulates	NULL
IB	NULL
by	NULL
two	NULL
distinct	NULL
mechanisms	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1266	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-KB	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
I	NULL
«	NULL
Ba	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912	NULL
.	NULL

Cheng	NULL
,	NULL
Q.	NULL
,	NULL
C.	NULL
A.	NULL
Cant	NULL
,	NULL
T.	NULL
Moll	NULL
,	NULL
R.	NULL
Hofer-Warbinck	NULL
,	NULL
E.	NULL
Wagner	NULL
,	NULL
M.	NULL
L.	NULL
Birnstiel	NULL
,	NULL
F.	NULL
H.	NULL
Bach	NULL
,	NULL
and	NULL
R.	NULL
de	NULL
Martin	NULL
.	NULL

1994	NULL
.	NULL

NF-kB	NULL
subunit-specific	NULL
regulation	NULL
of	NULL
the	NULL
Ik66	NULL
a	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:13551	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299	NULL
.	NULL

Kehlenbach	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
A.	NULL
Dickmanns	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
L.	NULL
Gerace	NULL
.	NULL

1998	NULL
.	NULL

Nucleocytoplasmic	NULL
shuttling	NULL
factors	NULL
including	NULL
Ran	NULL
and	NULL
CRM1	NULL
mediate	NULL
nuclear	NULL
export	NULL
of	NULL
NFAT	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:863	NULL
.	NULL

Beals	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
C.	NULL
M.	NULL
Sheridan	NULL
,	NULL
C.	NULL
W.	NULL
Turk	NULL
,	NULL
P.	NULL
Garduer	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
export	NULL
of	NULL
NF-ATc	NULL
enhanced	NULL
by	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
.	NULL

Science	NULL
275:1930	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
X.	NULL
Y.	NULL
Fu	NULL
,	NULL
T.	NULL
Improta	NULL
,	NULL
R.	NULL
Aebersold	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

Proteins	NULL
of	NULL
transcription	NULL
factor	NULL
ISGF-3	NULL
:	NULL
one	NULL
gene	NULL
encodes	NULL
the	NULL
Q1-and	NULL
84-kDa	NULL
ISGF-3	NULL
proteins	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
interferon	NULL
alpha	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7836	NULL
.	NULL

Sekimoto	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Tachibana	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
Y.	NULL
Yoneda	NULL
.	NULL

1996	NULL
.	NULL

Interferon-y-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
Statl	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
GTPase	NULL
activity	NULL
of	NULL
Ran/TC4	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:31017	NULL
.	NULL

Weis	NULL
,	NULL
K.	NULL
,	NULL
U.	NULL
Ryder	NULL
,	NULL
and	NULL
A.	NULL
I.	NULL
Lamond	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
conserved	NULL
amino-terminal	NULL
domain	NULL
of	NULL
hSRP1	NULL
@	NULL
is	NULL
essential	NULL
for	NULL
nuclear	NULL
protein	NULL
import	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1818	NULL
.	NULL

Nadler	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
D.	NULL
Tritschler	NULL
,	NULL
O.	NULL
K.	NULL
Haffar	NULL
,	NULL
J.	NULL
Blake	NULL
,	NULL
A.	NULL
G.	NULL
Bruce	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Cleaveland	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
expression	NULL
and	NULL
sequence-specific	NULL
interaction	NULL
of	NULL
karyopherin	NULL
a	NULL
with	NULL
nuclear	NULL
localization	NULL
sequences	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:4310	NULL
.	NULL

Xu	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
M.	NULL
Zutther	NULL
,	NULL
S.	NULL
A.	NULL
Santoro	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
F.	NULL
Clark	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
three-dimen-sional	NULL
collagen	NULL
lattice	NULL
activates	NULL
NF-kB	NULL
in	NULL
human	NULL
fibroblasts	NULL
:	NULL
role	NULL
in	NULL
integrin	NULL
a2	NULL
gene	NULL
expression	NULL
and	NULL
tissue	NULL
remodeling	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

140:709	NULL
.	NULL

Qin	NULL
,	NULL
Z.-H.	NULL
,	NULL
Y.	NULL
Wang	NULL
,	NULL
M.	NULL
Nakai	NULL
,	NULL
and	NULL
T.	NULL
N.	NULL
Chase	NULL
.	NULL

1998	NULL
.	NULL

Nuclear	NULL
factor-	NULL
«	NULL
B	NULL
contributes	NULL
to	NULL
excitotoxin-induced	NULL
apoptosis	NULL
in	NULL
rat	NULL
striatum	NULL
.	NULL

Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

53:33	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

